119 results on '"Eicosanoids immunology"'
Search Results
2. A complex immune communication between eicosanoids and pulmonary macrophages.
- Author
-
Pernet E, Poschmann J, and Divangahi M
- Subjects
- Humans, Animals, Lung immunology, Lung virology, Virus Diseases immunology, Respiratory Tract Infections immunology, Respiratory Tract Infections virology, Eicosanoids metabolism, Eicosanoids immunology, Macrophages, Alveolar immunology
- Abstract
Respiratory viral infections represent a constant threat for human health and urge for a better understanding of the pulmonary immune response to prevent disease severity. Macrophages are at the center of pulmonary immunity, where they play a pivotal role in orchestrating beneficial and/or pathological outcomes during infection. Eicosanoids, the host bioactive lipid mediators, have re-emerged as important regulators of pulmonary immunity during respiratory viral infections. In this review, we summarize the current knowledge linking eicosanoids' and pulmonary macrophages' homeostatic and antimicrobial functions and discuss eicosanoids as emerging targets for immunotherapy in viral infection., Competing Interests: Declaration of Competing Interest None., (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
3. Mepolizumab targets multiple immune cells in aspirin-exacerbated respiratory disease.
- Author
-
Buchheit KM, Lewis E, Gakpo D, Hacker J, Sohail A, Taliaferro F, Berreondo Giron E, Asare C, Vukovic M, Bensko JC, Dwyer DF, Shalek AK, Ordovas-Montanes J, and Laidlaw TM
- Subjects
- Adolescent, Adult, Aged, Eicosanoids immunology, Eicosanoids urine, Female, Humans, Interleukin-5 immunology, Interleukin-5 Receptor alpha Subunit immunology, Male, Middle Aged, Antibodies, Monoclonal, Humanized administration & dosage, Asthma, Aspirin-Induced drug therapy, Asthma, Aspirin-Induced immunology, Asthma, Aspirin-Induced urine, Basophils immunology, Basophils pathology, Eosinophils immunology, Eosinophils pathology, Nasal Polyps drug therapy, Nasal Polyps immunology, Nasal Polyps urine
- Abstract
Background: Eosinophilic asthma and nasal polyposis are hallmarks of aspirin-exacerbated respiratory disease (AERD), and IL-5 inhibition has been shown to provide therapeutic benefit. However, IL-5Rα is expressed on many cells in addition to eosinophils, and the mechanisms by which IL-5 inhibition leads to clinical benefit in eosinophilic asthma and nasal polyposis are unlikely to be due exclusively to antieosinophil effects., Objective: We sought to identify the mechanisms by which anti-IL-5 treatment with mepolizumab improves respiratory inflammation in AERD., Methods: The clinical characteristics, circulating granulocytes, nasal scraping transcripts, eosinophilic cationic protein, tryptase, and antibody levels, and urinary and nasal eicosanoid levels were measured for 18 subjects with AERD who were taking mepolizumab and compared with those of 18 matched subjects with AERD who were not taking mepolizumab., Results: Subjects taking mepolizumab had significantly fewer peripheral blood eosinophils and basophils, and those cells that remained had higher surface CRTH2 expression than did the cells from subjects not taking mepolizumab. Nasal prostaglandin F
2α , prostaglandin D2 metabolites, leukotriene B4 , and thromboxane levels were lower in subjects taking mepolizumab, as were urinary levels of tetranor-prostaglandin D2 and leukotriene E4 . The nasal epithelial cell transcripts that were overexpressed among subjects with AERD who were taking mepolizumab were enriched for genes involved in tight junction formation and cilium organization. Nasal and urinary prostaglandin E2 , tryptase, and antibody levels were not different between the 2 groups., Conclusion: IL-5 inhibition in AERD decreases production of inflammatory eicosanoids and upregulates tight junction-associated nasal epithelial cell transcripts, likely due to decreased IL-5 signaling on tissue mast cells, eosinophils, and epithelial cells. These direct effects on multiple relevant immune cells contribute to the mechanism of benefit afforded by mepolizumab., (Copyright © 2021. Published by Elsevier Inc.)- Published
- 2021
- Full Text
- View/download PDF
4. Chemokines and eicosanoids fuel the hyperinflammation within the lungs of patients with severe COVID-19.
- Author
-
Zaid Y, Doré É, Dubuc I, Archambault AS, Flamand O, Laviolette M, Flamand N, Boilard É, and Flamand L
- Subjects
- Adult, Aged, Bronchoalveolar Lavage Fluid cytology, Bronchoalveolar Lavage Fluid immunology, COVID-19 blood, Cytokines blood, Female, Humans, Inflammation blood, Lung cytology, Lymphocytes immunology, Male, Middle Aged, Neutrophils immunology, Severity of Illness Index, COVID-19 immunology, Cytokines immunology, Eicosanoids immunology, Inflammation immunology, Lung immunology, SARS-CoV-2
- Abstract
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can lead to a variety of clinical outcomes, ranging from the absence of symptoms to severe acute respiratory disease and ultimately death. A feature of patients with severe coronavirus disease 2019 (COVID-19) is the abundance of inflammatory cytokines in the blood. Elevated levels of cytokines are predictive of infection severity and clinical outcome. In contrast, studies aimed at defining the driving forces behind the inflammation in lungs of subjects with severe COVID-19 remain scarce., Objective: Our aim was to analyze and compare the plasma and bronchoalveolar lavage (BAL) fluids of patients with severe COVID-19 (n = 45) for the presence of cytokines and lipid mediators of inflammation (LMIs)., Methods: Cytokines were measured by using Luminex multiplex assay, and LMIs were measured by using liquid chromatography-tandem mass spectrometry., Results: We revealed high concentrations of numerous cytokines, chemokines, and LMIs in the BAL fluid of patients with severe COVID-19. Of the 13 most abundant mediators in BAL fluid, 11 were chemokines, with CXCL1 and CXCL8 being 200 times more abundant than IL-6 and TNF-α. Eicosanoid levels were also elevated in the lungs of subjects with severe COVID-19. Consistent with the presence chemotactic molecules, BAL fluid samples were enriched for neutrophils, lymphocytes, and eosinophils. Inflammatory cytokines and LMIs in plasma showed limited correlations with those present in BAL fluid, arguing that circulating inflammatory molecules may not be a reliable proxy of the inflammation occurring in the lungs of patients with severe COVID-19., Conclusions: Our findings indicate that hyperinflammation of the lungs of patients with severe COVID-19 is fueled by excessive production of chemokines and eicosanoids. Therapeutic strategies to dampen inflammation in patients with COVID-19 should be tailored accordingly., (Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
5. Eicosanoid Signaling in Insect Immunology: New Genes and Unresolved Issues.
- Author
-
Kim Y and Stanley D
- Subjects
- Animals, Arachidonic Acid genetics, Arachidonic Acid immunology, Eicosanoids biosynthesis, Eicosanoids immunology, Fatty Acid Desaturases genetics, Fatty Acid Desaturases immunology, Hemocytes enzymology, Insecta immunology, Insecta metabolism, Lipoxygenase genetics, Lipoxygenase immunology, Mammals genetics, Mammals immunology, Phospholipases A2 immunology, Platelet Activating Factor analogs & derivatives, Platelet Activating Factor genetics, Platelet Activating Factor immunology, Prostaglandin-Endoperoxide Synthases genetics, Eicosanoids genetics, Insecta genetics, Phospholipases A2 genetics, Signal Transduction genetics
- Abstract
This paper is focused on eicosanoid signaling in insect immunology. We begin with eicosanoid biosynthesis through the actions of phospholipase A
2 , responsible for hydrolyzing the C18 polyunsaturated fatty acid, linoleic acid (18:2n-6), from cellular phospholipids, which is subsequently converted into arachidonic acid (AA; 20:4n-6) via elongases and desaturases. The synthesized AA is then oxygenated into one of three groups of eicosanoids, prostaglandins (PGs), epoxyeicosatrienoic acids (EETs) and lipoxygenase products. We mark the distinction between mammalian cyclooxygenases and insect peroxynectins, both of which convert AA into PGs. One PG, PGI2 (also called prostacyclin), is newly discovered in insects, as a negative regulator of immune reactions and a positive signal in juvenile development. Two new elements of insect PG biology are a PG dehydrogenase and a PG reductase, both of which enact necessary PG catabolism. EETs, which are produced from AA via cytochrome P450s, also act in immune signaling, acting as pro-inflammatory signals. Eicosanoids signal a wide range of cellular immune reactions to infections, invasions and wounding, including nodulation, cell spreading, hemocyte migration and releasing prophenoloxidase from oenocytoids, a class of lepidopteran hemocytes. We briefly review the relatively scant knowledge on insect PG receptors and note PGs also act in gut immunity and in humoral immunity. Detailed new information on PG actions in mosquito immunity against the malarial agent, Plasmodium berghei , has recently emerged and we treat this exciting new work. The new findings on eicosanoid actions in insect immunity have emerged from a very broad range of research at the genetic, cellular and organismal levels, all taking place at the international level.- Published
- 2021
- Full Text
- View/download PDF
6. Tuft cells in the pathogenesis of chronic rhinosinusitis with nasal polyps and asthma.
- Author
-
Sell EA, Ortiz-Carpena JF, Herbert DR, and Cohen NA
- Subjects
- Acetylcholine immunology, Animals, Chronic Disease, Eicosanoids immunology, Humans, Interleukin-17 immunology, Respiratory System immunology, Asthma immunology, Epithelial Cells immunology, Nasal Polyps immunology, Respiratory System cytology, Rhinitis immunology, Sinusitis immunology
- Abstract
Objective: To review the latest discoveries regarding the role of tuft cells in the pathogenesis of chronic rhinosinusitis (CRS) with nasal polyposis and asthma., Data Sources: Reviews and primary research manuscripts were identified from PubMed, Google, and bioRxiv using the search words airway epithelium, nasal polyposis, CRS or asthma and chemoreceptor cell, solitary chemosensory cell, brush cell, microvillus cell, and tuft cell., Study Selections: Studies were selected on the basis of novelty and likely relevance to the functions of tuft cells in chronic inflammatory diseases in the upper and lower airways., Results: Tuft cells coordinate a variety of immune responses throughout the body. After the activation of bitter-taste receptors, tuft cells coordinate the secretion of antimicrobial products by adjacent epithelial cells and initiate the calcium-dependent release of acetylcholine resulting in neurogenic inflammation, including mast cell degranulation and plasma extravasation. Tuft cells are also the dominant source of interleukin-25 and a significant source of cysteinyl leukotrienes that play a role in initiating inflammatory processes in the airway. Tuft cells have also been found to seem de novo in the distal airway after a viral infection, implicating these cells in dysplastic remodeling in the distal lung in the pathogenesis of asthma., Conclusion: Tuft cells bridge innate and adaptive immunes responses and play an upstream role in initiating type 2 inflammation in the upper and possibly the lower airway. The role of tuft cells in respiratory pathophysiology must be further investigated, because tuft cells are putative high-value therapeutic targets for novel therapeutics in CRS with nasal polyps and asthma., (Copyright © 2020. Published by Elsevier Inc.)
- Published
- 2021
- Full Text
- View/download PDF
7. Cutting Edge: Severe SARS-CoV-2 Infection in Humans Is Defined by a Shift in the Serum Lipidome, Resulting in Dysregulation of Eicosanoid Immune Mediators.
- Author
-
Schwarz B, Sharma L, Roberts L, Peng X, Bermejo S, Leighton I, Casanovas-Massana A, Minasyan M, Farhadian S, Ko AI, Dela Cruz CS, and Bosio CM
- Subjects
- Adult, Aged, Aged, 80 and over, Arachidonate 12-Lipoxygenase immunology, Arachidonate 12-Lipoxygenase metabolism, Arachidonate 5-Lipoxygenase immunology, Arachidonate 5-Lipoxygenase metabolism, Biomarkers blood, Cyclooxygenase 2 immunology, Cyclooxygenase 2 metabolism, Female, Humans, Male, Middle Aged, COVID-19 blood, COVID-19 immunology, Eicosanoids blood, Eicosanoids immunology, Lipidomics, SARS-CoV-2 immunology, SARS-CoV-2 metabolism
- Abstract
The COVID-19 pandemic has affected more than 20 million people worldwide, with mortality exceeding 800,000 patients. Risk factors associated with severe disease and mortality include advanced age, hypertension, diabetes, and obesity. Each of these risk factors pathologically disrupts the lipidome, including immunomodulatory eicosanoid and docosanoid lipid mediators (LMs). We hypothesized that dysregulation of LMs may be a defining feature of the severity of COVID-19. By examining LMs and polyunsaturated fatty acid precursor lipids in serum from hospitalized COVID-19 patients, we demonstrate that moderate and severe disease are separated by specific differences in abundance of immune-regulatory and proinflammatory LMs. This difference in LM balance corresponded with decreased LM products of ALOX12 and COX2 and an increase LMs products of ALOX5 and cytochrome p450. Given the important immune-regulatory role of LMs, these data provide mechanistic insight into an immuno-lipidomic imbalance in severe COVID-19., (Copyright © 2021 by The American Association of Immunologists, Inc.)
- Published
- 2021
- Full Text
- View/download PDF
8. The roles of lipids in SARS-CoV-2 viral replication and the host immune response.
- Author
-
Theken KN, Tang SY, Sengupta S, and FitzGerald GA
- Subjects
- Humans, COVID-19 immunology, Cell Membrane immunology, Eicosanoids immunology, SARS-CoV-2 physiology, Sphingolipids immunology, Virus Replication immunology
- Abstract
The significant morbidity and mortality associated with severe acute respiratory syndrome coronavirus 2 infection has underscored the need for novel antiviral strategies. Lipids play essential roles in the viral life cycle. The lipid composition of cell membranes can influence viral entry by mediating fusion or affecting receptor conformation. Upon infection, viruses can reprogram cellular metabolism to remodel lipid membranes and fuel the production of new virions. Furthermore, several classes of lipid mediators, including eicosanoids and sphingolipids, can regulate the host immune response to viral infection. Here, we summarize the existing literature on the mechanisms through which these lipid mediators may regulate viral burden in COVID-19. Furthermore, we define the gaps in knowledge and identify the core areas in which lipids offer therapeutic promise for severe acute respiratory syndrome coronavirus 2., Competing Interests: Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article., (Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
9. Eicosanoid production varies by sex in mesenteric ischemia reperfusion injury.
- Author
-
Wu M, Rowe JM, and Fleming SD
- Subjects
- Animals, Complement C5a immunology, Cytokines immunology, Eicosanoids immunology, Female, Intestinal Mucosa immunology, Intestinal Mucosa pathology, Intestine, Small immunology, Intestine, Small pathology, Macrophages immunology, Male, Mice, Inbred C57BL, Neutrophil Infiltration, Peroxidase immunology, Reperfusion Injury pathology, Dinoprostone immunology, Leukotriene B4 immunology, Mesentery blood supply, Reperfusion Injury immunology, Sex Characteristics
- Abstract
Intestinal ischemia/reperfusion (I/R)-induced injury is an inflammatory response with significant morbidity and mortality. The early inflammatory response includes neutrophil infiltration. However, the majority of rodent studies utilize male mice despite a sexual dimorphism in intestinal I/R-related diseases. We hypothesized that sex may alter inflammation by changing neutrophil infiltration and eicosanoid production. To test this hypothesis, male and female C57Bl/6 mice were subjected to sham treatment or 30 min intestinal ischemia followed by a time course of reperfusion. We demonstrate that compared to male mice, females sustain significantly less intestinal I/R-induced tissue damage and produced significant LTB
4 concentrations. Male mice release PGE2 . Finally, treatment with a COX-2 specific inhibitor, NS-398, attenuated I/R-induced injury, total peroxidase level, and PGE2 production in males, but not in similarly treated female mice. Thus, I/R-induced eicosanoid production and neutrophil infiltration varies between sexes suggesting that distinct therapeutic intervention may be needed in clinical ischemic diseases., Competing Interests: Declaration of Competing Interest None of the authors has any potential financial conflict of interest related to this manuscript., (Copyright © 2020 Elsevier Inc. All rights reserved.)- Published
- 2020
- Full Text
- View/download PDF
10. Eicosanoids.
- Author
-
Calder PC
- Subjects
- Arachidonic Acid metabolism, Arthritis, Rheumatoid metabolism, Asthma metabolism, Cyclooxygenase Inhibitors pharmacology, Eicosanoids antagonists & inhibitors, Humans, Inflammatory Bowel Diseases metabolism, Lipoxygenase metabolism, NADPH-Ferrihemoprotein Reductase metabolism, Neoplasms metabolism, Prostaglandin-Endoperoxide Synthases metabolism, Receptors, Eicosanoid metabolism, Eicosanoids biosynthesis, Eicosanoids immunology
- Abstract
This article describes the pathways of eicosanoid synthesis, eicosanoid receptors, the action of eicosanoids in different physiological systems, the roles of eicosanoids in selected diseases, and the major inhibitors of eicosanoid synthesis and action. Eicosanoids are oxidised derivatives of 20-carbon polyunsaturated fatty acids (PUFAs) formed by the cyclooxygenase (COX), lipoxygenase (LOX) and cytochrome P450 (cytP450) pathways. Arachidonic acid (ARA) is the usual substrate for eicosanoid synthesis. The COX pathways form prostaglandins (PGs) and thromboxanes (TXs), the LOX pathways form leukotrienes (LTs) and lipoxins (LXs), and the cytP450 pathways form various epoxy, hydroxy and dihydroxy derivatives. Eicosanoids are highly bioactive acting on many cell types through cell membrane G-protein coupled receptors, although some eicosanoids are also ligands for nuclear receptors. Because they are rapidly catabolised, eicosanoids mainly act locally to the site of their production. Many eicosanoids have multiple, sometimes pleiotropic, effects on inflammation and immunity. The most widely studied is PGE2. Many eicosanoids have roles in the regulation of the vascular, renal, gastrointestinal and female reproductive systems. Despite their vital role in physiology, eicosanoids are often associated with disease, including inflammatory disease and cancer. Inhibitors have been developed that interfere with the synthesis or action of various eicosanoids and some of these are used in disease treatment, especially for inflammation., (© 2020 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.)
- Published
- 2020
- Full Text
- View/download PDF
11. Resolution of eicosanoid/cytokine storm prevents carcinogen and inflammation-initiated hepatocellular cancer progression.
- Author
-
Fishbein A, Wang W, Yang H, Yang J, Hallisey VM, Deng J, Verheul SML, Hwang SH, Gartung A, Wang Y, Bielenberg DR, Huang S, Kieran MW, Hammock BD, and Panigrahy D
- Subjects
- Aflatoxin B1 adverse effects, Animals, Apoptosis, Carcinogenesis metabolism, Carcinogens metabolism, Carcinoma, Hepatocellular metabolism, Cell Line, Cyclooxygenase 2 metabolism, Cytokines immunology, Disease Progression, Eicosanoids immunology, Epoxide Hydrolases metabolism, Hep G2 Cells, Humans, Inflammation metabolism, Liver Neoplasms physiopathology, Macrophages metabolism, Mice, Neoplastic Processes, Cytokines metabolism, Eicosanoids metabolism, Liver Neoplasms metabolism
- Abstract
Toxic environmental carcinogens promote cancer via genotoxic and nongenotoxic pathways, but nongenetic mechanisms remain poorly characterized. Carcinogen-induced apoptosis may trigger escape from dormancy of microtumors by interfering with inflammation resolution and triggering an endoplasmic reticulum (ER) stress response. While eicosanoid and cytokine storms are well-characterized in infection and inflammation, they are poorly characterized in cancer. Here, we demonstrate that carcinogens, such as aflatoxin B
1 (AFB1 ), induce apoptotic cell death and the resulting cell debris stimulates hepatocellular carcinoma (HCC) tumor growth via an "eicosanoid and cytokine storm." AFB1 -generated debris up-regulates cyclooxygenase-2 (COX-2), soluble epoxide hydrolase (sEH), ER stress-response genes including BiP , CHOP , and PDI in macrophages. Thus, selective cytokine or eicosanoid blockade is unlikely to prevent carcinogen-induced cancer progression. Pharmacological abrogation of both the COX-2 and sEH pathways by PTUPB prevented the debris-stimulated eicosanoid and cytokine storm, down-regulated ER stress genes, and promoted macrophage phagocytosis of debris, resulting in suppression of HCC tumor growth. Thus, inflammation resolution via dual COX-2/sEH inhibition is an approach to prevent carcinogen-induced cancer., Competing Interests: The authors declare no competing interest.- Published
- 2020
- Full Text
- View/download PDF
12. Impact of Androgens on Inflammation-Related Lipid Mediator Biosynthesis in Innate Immune Cells.
- Author
-
Pace S and Werz O
- Subjects
- Androgens immunology, Animals, Eicosanoids immunology, Female, Humans, Inflammation immunology, Inflammation metabolism, Inflammation Mediators immunology, Lipids immunology, Macrophages immunology, Macrophages metabolism, Male, Monocytes immunology, Monocytes metabolism, Neutrophils immunology, Neutrophils metabolism, Androgens metabolism, Eicosanoids metabolism, Immunity, Innate immunology, Inflammation Mediators metabolism
- Abstract
Rheumatoid arthritis, asthma, allergic rhinitis and many other disorders related to an aberrant immune response have a higher incidence and severity in women than in men. Emerging evidences from scientific studies indicate that the activity of the immune system is superior in females and that androgens may act as "immunosuppressive" molecules with inhibitory effects on inflammatory reactions. Among the multiple factors that contribute to the inflammatory response, lipid mediators (LM), produced from polyunsaturated fatty acids, represent a class of bioactive small molecules with pivotal roles in the onset, maintenance and resolution of inflammation. LM encompass pro-inflammatory eicosanoids and specialized pro-resolving mediators (SPM) that coexist in a tightly regulated balance necessary for the return to homeostasis. Innate immune cells including neutrophils, monocytes and macrophages possess high capacities to generate distinct LM. In the last decades it became more and more evident that sex represents an important variable in the regulation of inflammation where sex hormones play crucial roles. Recent findings showed that the biosynthesis of inflammation-related LM is sex-biased and that androgens impact LM formation with consequences not only for pathophysiology but also for pharmacotherapy. Here, we review the modulation of the inflammatory response by sex and androgens with a specific focus on LM pathways. In particular, we highlight the impact of androgens on the biosynthetic pathway of inflammation-related eicosanoids in innate immune cells., (Copyright © 2020 Pace and Werz.)
- Published
- 2020
- Full Text
- View/download PDF
13. Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?
- Author
-
Panigrahy D, Gilligan MM, Huang S, Gartung A, Cortés-Puch I, Sime PJ, Phipps RP, Serhan CN, and Hammock BD
- Subjects
- Anti-Inflammatory Agents, Non-Steroidal pharmacology, Betacoronavirus isolation & purification, COVID-19, Clinical Trials as Topic, Coronavirus Infections complications, Coronavirus Infections immunology, Coronavirus Infections virology, Cytokine Release Syndrome immunology, Cytokines immunology, Cytokines metabolism, Eicosanoids immunology, Eicosanoids metabolism, Epoxide Hydrolases antagonists & inhibitors, Epoxide Hydrolases metabolism, Humans, Macrophages immunology, Macrophages metabolism, Pandemics, Pneumonia, Viral complications, Pneumonia, Viral immunology, Pneumonia, Viral virology, Pulmonary Alveoli immunology, Pulmonary Alveoli metabolism, Pulmonary Alveoli virology, Respiratory Distress Syndrome immunology, SARS-CoV-2, Anti-Inflammatory Agents, Non-Steroidal therapeutic use, Antiviral Agents therapeutic use, Betacoronavirus immunology, Coronavirus Infections drug therapy, Cytokine Release Syndrome drug therapy, Pneumonia, Viral drug therapy, Respiratory Distress Syndrome therapy
- Abstract
Severe coronavirus disease (COVID-19) is characterized by pulmonary hyper-inflammation and potentially life-threatening "cytokine storms". Controlling the local and systemic inflammatory response in COVID-19 may be as important as anti-viral therapies. Endogenous lipid autacoid mediators, referred to as eicosanoids, play a critical role in the induction of inflammation and pro-inflammatory cytokine production. SARS-CoV-2 may trigger a cell death ("debris")-induced "eicosanoid storm", including prostaglandins and leukotrienes, which in turn initiates a robust inflammatory response. A paradigm shift is emerging in our understanding of the resolution of inflammation as an active biochemical process with the discovery of novel endogenous specialized pro-resolving lipid autacoid mediators (SPMs), such as resolvins. Resolvins and other SPMs stimulate macrophage-mediated clearance of debris and counter pro-inflammatory cytokine production, a process called inflammation resolution. SPMs and their lipid precursors exhibit anti-viral activity at nanogram doses in the setting of influenza without being immunosuppressive. SPMs also promote anti-viral B cell antibodies and lymphocyte activity, highlighting their potential use in the treatment of COVID-19. Soluble epoxide hydrolase (sEH) inhibitors stabilize arachidonic acid-derived epoxyeicosatrienoic acids (EETs), which also stimulate inflammation resolution by promoting the production of pro-resolution mediators, activating anti-inflammatory processes, and preventing the cytokine storm. Both resolvins and EETs also attenuate pathological thrombosis and promote clot removal, which is emerging as a key pathology of COVID-19 infection. Thus, both SPMs and sEH inhibitors may promote the resolution of inflammation in COVID-19, thereby reducing acute respiratory distress syndrome (ARDS) and other life-threatening complications associated with robust viral-induced inflammation. While most COVID-19 clinical trials focus on "anti-viral" and "anti-inflammatory" strategies, stimulating inflammation resolution is a novel host-centric therapeutic avenue. Importantly, SPMs and sEH inhibitors are currently in clinical trials for other inflammatory diseases and could be rapidly translated for the management of COVID-19 via debris clearance and inflammatory cytokine suppression. Here, we discuss using pro-resolution mediators as a potential complement to current anti-viral strategies for COVID-19.
- Published
- 2020
- Full Text
- View/download PDF
14. A twist of FATe: Lipid droplets and inflammatory lipid mediators.
- Author
-
Jarc E and Petan T
- Subjects
- Adipose Tissue immunology, Animals, Docosahexaenoic Acids immunology, Docosahexaenoic Acids metabolism, Eicosanoids immunology, Gene Expression Regulation, Homeostasis genetics, Homeostasis immunology, Humans, Inflammation, Lipase genetics, Lipase immunology, Lipid Droplets immunology, Lipid Metabolism immunology, Phospholipases genetics, Phospholipases immunology, Phospholipids immunology, Signal Transduction, Toll-Like Receptors genetics, Toll-Like Receptors immunology, Triglycerides immunology, Adipose Tissue metabolism, Eicosanoids metabolism, Lipid Droplets metabolism, Lipid Metabolism genetics, Phospholipids metabolism, Triglycerides metabolism
- Abstract
Lipid droplets are fat storage organelles present in most eukaryotic cells. They consist of a neutral lipid core containing mostly triglycerides and sterol esters and covered by a monolayer of phospholipids, wherein numerous proteins are embedded. In the cell, lipid droplets have a dynamic life cycle, rapidly altering their size, location, lipid and protein composition in response to environmental stimuli and cell state. Lipid droplets are primarily involved in the coordination of lipid metabolism with cellular requirements for energy production, membrane homeostasis and cell growth. However, they are also directly or indirectly engaged in signalling pathways. On the one hand, lipid droplets sequester lipids and proteins thereby limiting their availability for participation in signalling pathways. On the other hand, the lipolytic machinery provides a highly regulated, on-demand source of signalling lipids: lipids derived from their neutral lipid core, or the phospholipid monolayer, directly act as signalling mediators or are converted into ones. In fact, emerging studies suggest that these organelles are essential for various cellular stress response mechanisms, including inflammation and immunity, acting as hubs that integrate metabolic and inflammatory processes. Here, we discuss the ways in which lipid droplets regulate the availability of fatty acids for the activation of signalling pathways and for the production of polyunsaturated fatty acid-derived lipid mediators. We focus in particular on recent discoveries in immune cells and adipose tissue that have revealed an intricate relationship between lipid droplets and inflammatory signalling and may also be relevant for other tissues and various human diseases., (Copyright © 2019 The Author(s). Published by Elsevier B.V. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
15. The impact of recent advances in lipidomics and redox lipidomics on dermatological research.
- Author
-
Gruber F, Kremslehner C, and Narzt MS
- Subjects
- Acne Vulgaris diagnosis, Acne Vulgaris immunology, Acne Vulgaris pathology, Adult, Autoantigens immunology, Autoantigens metabolism, Biomarkers metabolism, Ceramides immunology, Child, Dermatitis, Atopic diagnosis, Dermatitis, Atopic immunology, Dermatitis, Atopic pathology, Eicosanoids immunology, Fetus, Humans, Lipid Metabolism, Oxidation-Reduction, Psoriasis diagnosis, Psoriasis immunology, Psoriasis pathology, Signal Transduction, Skin metabolism, Skin pathology, T-Lymphocytes immunology, T-Lymphocytes pathology, Acne Vulgaris metabolism, Ceramides metabolism, Dermatitis, Atopic metabolism, Eicosanoids metabolism, Lipidomics trends, Psoriasis metabolism
- Abstract
Dermatological research is a major beneficiary of the rapidly developing advances in lipid analytic technology and of bioinformatic tools which help to decipher and interpret the accumulating big lipid data. At its interface with the environment, the epidermis develops a blend of lipids that constitutes the epidermal lipid barrier, essential for the protection from water loss and entry of dangerous noxae. Apart from their structural role in the barrier, novel intra- and inter-cellular signaling functions of lipids and their oxidation products have been uncovered in most cutaneous cell types over the last decades, and the discovery rate has been boosted by the advent of high resolution and -throughput mass spectrometric techniques. Our understanding of epidermal development has benefited from studies on fetal surface lipids, which appear to signal for adaptation to desiccation post partum, and from studies on the dynamics of epidermal lipids during adjustment to the atmosphere in the first months of life. At birth, external insults begin to challenge the skin and its lipids, and recent years have yielded ample insights into the dynamics of lipid synthesis and -oxdiation after UV exposure, and upon contact with sensitizers and irritants. Psoriasis and atopic dermatitis are the most common chronic inflammatory skin diseases, affecting at least 3% and 7% of the global population, respectively. Consequently, novel (redox-) lipidomic techniques have been applied to study systemic and topical lipid abnormalities in patient cohorts. These studies have refined the knowledge on eicosanoid signaling in both diseases, and have identified novel biomarkers and potential disease mediators, such as lipid antigens recognized by psoriatic T cells, as well as ceramide species, which specifically correlate with atopic dermatitis severity. Both biomarkers have yielded novel mechanistic insights. Finally, the technological progress has enabled studies to be performed that have monitored the consequences of diet, lifestyle, therapy and cosmetic intervention on the skin lipidome, highlighting the translational potential of (redox-) lipidomics in dermatology., (Copyright © 2019 Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
16. Plasma Eicosanoid Profile in Plasmodium vivax Malaria: Clinical Analysis and Impacts of Self-Medication.
- Author
-
Abreu-Filho PG, Tarragô AM, Costa AG, Monteiro WM, Meielles AFG, Costa TCC, Silva JS, Zambuzi FA, Gardinassi LG, Moraes LAB, Lacerda MVG, Sorgi CA, Faccioli LH, and Malheiro A
- Subjects
- Adult, Anti-Inflammatory Agents therapeutic use, Cytokines blood, Cytokines immunology, Eicosanoids immunology, Female, Humans, Malaria, Vivax drug therapy, Male, Middle Aged, Eicosanoids blood, Malaria, Vivax blood, Malaria, Vivax immunology
- Abstract
The participation of cytokines and chemokines in Plasmodium vivax malaria ( Pv -malaria) activates the immune response and thus causes the production of several inflammatory mediators. This process is already well-established, but little is known about eicosanoids in malaria physiopathology, especially in regards to inflammation and immunity. Malaria is an acute febrile syndrome similar to any other less important infectious disease and people may self-medicate with any anti-inflammatory drugs in order to cease the recurrent symptoms of the disease. Based on this information, the study describes the eicosanoid profile and its possible influence on the production of cytokines and chemokines in P. vivax infections. In addition, we investigated the influence of self-medication with anti-inflammatory drugs in this immune profile. Twenty-three patients were included in the study, with or without self-medication by anti-inflammatory drugs prior to diagnosis. A total 12 individuals were selected for the control group. Eicosanoid profiles were quantified by HPLC-MS/MS, and cytokines and chemokines by flow cytometry and ELISA. The Pv -malaria infection significantly reduces the production of several lipid mediators, and its action is increased by self-medication. We observed that the eicosanoids we found derive from the lipoxygenase and cyclooxygenase pathways, and present positive and negative correlations with chemokines and cytokines in the follow-up of patients. Our data suggest that self-medication may interfere in the immunological characteristics in P. vivax infection and may modify the follow-up of the disease., (Copyright © 2019 Abreu-Filho, Tarragô, Costa, Monteiro, Meielles, Costa, Silva, Zambuzi, Gardinassi, Moraes, Lacerda, Sorgi, Faccioli and Malheiro.)
- Published
- 2019
- Full Text
- View/download PDF
17. 15-keto-prostaglandin E2 activates host peroxisome proliferator-activated receptor gamma (PPAR-γ) to promote Cryptococcus neoformans growth during infection.
- Author
-
Evans RJ, Pline K, Loynes CA, Needs S, Aldrovandi M, Tiefenbach J, Bielska E, Rubino RE, Nicol CJ, May RC, Krause HM, O'Donnell VB, Renshaw SA, and Johnston SA
- Subjects
- Animals, Animals, Genetically Modified, Cell Culture Techniques, Cryptococcosis metabolism, Cryptococcus neoformans growth & development, Cryptococcus neoformans pathogenicity, Dinoprostone metabolism, Dinoprostone physiology, Disease Models, Animal, Eicosanoids immunology, Host-Pathogen Interactions physiology, Humans, Macrophages microbiology, PPAR gamma metabolism, Virulence physiology, Zebrafish microbiology, Cryptococcus neoformans metabolism, Dinoprostone analogs & derivatives, Eicosanoids metabolism
- Abstract
Cryptococcus neoformans is one of the leading causes of invasive fungal infection in humans worldwide. C. neoformans uses macrophages as a proliferative niche to increase infective burden and avoid immune surveillance. However, the specific mechanisms by which C. neoformans manipulates host immunity to promote its growth during infection remain ill-defined. Here we demonstrate that eicosanoid lipid mediators manipulated and/or produced by C. neoformans play a key role in regulating pathogenesis. C. neoformans is known to secrete several eicosanoids that are highly similar to those found in vertebrate hosts. Using eicosanoid deficient cryptococcal mutants Δplb1 and Δlac1, we demonstrate that prostaglandin E2 is required by C. neoformans for proliferation within macrophages and in vivo during infection. Genetic and pharmacological disruption of host PGE2 synthesis is not required for promotion of cryptococcal growth by eicosanoid production. We find that PGE2 must be dehydrogenated into 15-keto-PGE2 to promote fungal growth, a finding that implicated the host nuclear receptor PPAR-γ. C. neoformans infection of macrophages activates host PPAR-γ and its inhibition is sufficient to abrogate the effect of 15-keto-PGE2 in promoting fungal growth during infection. Thus, we describe the first mechanism of reliance on pathogen-derived eicosanoids in fungal pathogenesis and the specific role of 15-keto-PGE2 and host PPAR-γ in cryptococcosis., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2019
- Full Text
- View/download PDF
18. Dietary ω-3 fatty acids alter the lipid mediator profile and alleviate allergic conjunctivitis without modulating T h 2 immune responses.
- Author
-
Hirakata T, Lee HC, Ohba M, Saeki K, Okuno T, Murakami A, Matsuda A, and Yokomizo T
- Subjects
- Animals, Asthma immunology, Chemokines immunology, Cytokines immunology, Diet methods, Eicosanoids immunology, Eosinophils immunology, Female, Immunoglobulin E immunology, Mice, Mice, Inbred BALB C, Conjunctivitis, Allergic immunology, Fatty Acids, Omega-3 immunology, Lipids immunology, Th2 Cells immunology
- Abstract
Allergic conjunctivitis (AC) is one of the most common ocular surface diseases in the world. In AC, T helper type 2 (T
h 2) immune responses play central roles in orchestrating inflammatory responses. However, the roles of lipid mediators in the onset and progression of AC remain to be fully explored. Although previous reports have shown the beneficial effects of supplementation of ω-3 fatty acids in asthma or atopic dermatitis, the underlying molecular mechanisms are poorly understood. In this study, a diet rich in ω-3 fatty acids alleviated AC symptoms in both early and late phases without affecting Th 2 immune responses, but rather by altering the lipid mediator profiles. The ω-3 fatty acids completely suppressed scratching behavior toward the eyes, an allergic reaction provoked by itch. Although total serum IgE levels and the expression levels of Th 2 cytokines and chemokines in the conjunctiva were not altered by ω-3 fatty acids, eosinophil infiltration into the conjunctiva was dramatically suppressed. The levels of ω-6-derived proinflammatory lipid mediators, including those with chemoattractant properties for eosinophils, were markedly reduced in the conjunctivae of ω-3 diet-fed mice. Dietary ω-3 fatty acids can alleviate a variety of symptoms of AC by altering the lipid mediator profile.-Hirakata, T., Lee, H.-C., Ohba, M., Saeki, K., Okuno, T., Murakami, A., Matsuda, A., Yokomizo, T. Dietary ω-3 fatty acids alter the lipid mediator profile and alleviate allergic conjunctivitis without modulating Th 2 immune responses.- Published
- 2019
- Full Text
- View/download PDF
19. COX-1 mediates IL-33-induced extracellular signal-regulated kinase activation in mast cells: Implications for aspirin sensitivity.
- Author
-
Pan D, Buchheit KM, Samuchiwal SK, Liu T, Cirka H, Raff H, and Boyce JA
- Subjects
- Animals, Cells, Cultured, Cyclooxygenase 2 immunology, Cyclooxygenase Inhibitors pharmacology, Eicosanoids immunology, Mice, Inbred C57BL, Mice, Knockout, Phospholipases A2, Cytosolic immunology, Asthma, Aspirin-Induced immunology, Cyclooxygenase 1 immunology, Extracellular Signal-Regulated MAP Kinases immunology, Interleukin-33 immunology, Mast Cells immunology, Membrane Proteins immunology
- Abstract
Background: Classical FcεRI-induced mast cell (MC) activation causes synthesis of arachidonic acid (AA)-derived eicosanoids (leukotriene [LT] C
4 , prostaglandin [PG] D2 , and thromboxane A2 ), which mediate vascular leak, bronchoconstriction, and effector cell chemotaxis. Little is known about the significance and regulation of eicosanoid generation in response to nonclassical MC activation mechanisms., Objectives: We sought to determine the regulation and significance of MC-derived eicosanoids synthesized in response to IL-33, a cytokine critical to innate type 2 immunity., Methods: We used an ex vivo model of mouse bone marrow-derived mast cells and an IL-33-dependent in vivo model of aspirin-exacerbated respiratory disease (AERD)., Results: IL-33 potently liberates AA and elicits LTC4 , PGD2 , and thromboxane A2 production by bone marrow-derived mast cells. Unexpectedly, the constitutive function of COX-1 is required for IL-33 to activate group IVa cytosolic phospholipase A2 with consequent AA release for synthesis of all eicosanoids, including CysLTs. In contrast, COX-1 was dispensable for FcεRI-driven CysLT production. Inhibition of COX-1 prevented IL-33-induced phosphorylation of extracellular signal-related kinase, an upstream effector of cytosolic phospholipase A2 , which was restored by exogenous PGH2 , implying that the effects of COX-1 required its catalytic function. Administration of a COX-1-selective antagonist to mice completely prevented the generation of both PGD2 and LTC4 in a model of AERD in which MC activation is IL-33 driven., Conclusions: MC-intrinsic COX-1 amplifies IL-33-induced activation in the setting of innate type 2 immunity and might help explain the phenomenon of therapeutic desensitization to aspirin by nonselective COX inhibitors in patients with AERD., (Copyright © 2018 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.)- Published
- 2019
- Full Text
- View/download PDF
20. Eicosanoid Control Over Antigen Presenting Cells in Asthma.
- Author
-
Debeuf N and Lambrecht BN
- Subjects
- Animals, Antigen Presentation, Cell Degranulation, Cytokines metabolism, Eicosanoids immunology, Humans, Immunity, Innate, Lymphocyte Activation, Antigen-Presenting Cells immunology, Asthma immunology, Eicosanoids metabolism, Eosinophils immunology, Inflammation immunology, Th17 Cells immunology, Th2 Cells immunology
- Abstract
Asthma is a common lung disease affecting 300 million people worldwide. Allergic asthma is recognized as a prototypical Th2 disorder, orchestrated by an aberrant adaptive CD4+ T helper (Th2/Th17) cell immune response against airborne allergens, that leads to eosinophilic inflammation, reversible bronchoconstriction, and mucus overproduction. Other forms of asthma are controlled by an eosinophil-rich innate ILC2 response driven by epithelial damage, whereas in some patients with more neutrophilia, the disease is driven by Th17 cells. Dendritic cells (DCs) and macrophages are crucial regulators of type 2 immunity in asthma. Numerous lipid mediators including the eicosanoids prostaglandins and leukotrienes influence key functions of these cells, leading to either pro- or anti-inflammatory effects on disease outcome. In this review, we will discuss how eicosanoids affect the functions of DCs and macrophages in the asthmatic lung and how this leads to aberrant T cell differentiation that causes disease.
- Published
- 2018
- Full Text
- View/download PDF
21. Pro-resolving mediators promote resolution in a human skin model of UV-killed Escherichia coli-driven acute inflammation.
- Author
-
Motwani MP, Colas RA, George MJ, Flint JD, Dalli J, Richard-Loendt A, De Maeyer RP, Serhan CN, and Gilroy DW
- Subjects
- Adaptor Proteins, Signal Transducing metabolism, Adolescent, Adult, Blister immunology, Blister metabolism, Chemokines metabolism, Cytokines metabolism, Docosahexaenoic Acids pharmacology, Eicosanoids immunology, Eicosanoids pharmacology, Eicosapentaenoic Acid analogs & derivatives, Eicosapentaenoic Acid pharmacology, Escherichia coli radiation effects, Humans, Inflammation drug therapy, Leukocytes immunology, Leukocytes metabolism, Lipoxins pharmacology, Male, Middle Aged, Neutrophils drug effects, Receptors, Chemokine metabolism, Receptors, Formyl Peptide metabolism, Receptors, G-Protein-Coupled, Receptors, Lipoxin metabolism, Skin drug effects, Skin pathology, Volunteers, Young Adult, Anti-Inflammatory Agents pharmacology, Escherichia coli immunology, Inflammation immunology, Inflammation metabolism, Skin immunology, Skin metabolism
- Abstract
While the treatment of inflammatory disorders is generally based on inhibiting factors that drive onset of inflammation, these therapies can compromise healing (NSAIDs) or dampen immunity against infections (biologics). In search of new antiinflammatories, efforts have focused on harnessing endogenous pathways that drive resolution of inflammation for therapeutic gain. Identification of specialized pro-resolving mediators (SPMs) (lipoxins, resolvins, protectins, maresins) as effector molecules of resolution has shown promise in this regard. However, their action on inflammatory resolution in humans is unknown. Here, we demonstrate using a model of UV-killed Escherichia coli-triggered skin inflammation that SPMs are biosynthesized at the local site at the start of resolution, coinciding with the expression of receptors that transduce their actions. These include receptors for lipoxin A4 (ALX/FPR2), resolvin E1 (ChemR23), resolvin D2 (GPR18), and resolvin D1 (GPR32) that were differentially expressed on the endothelium and infiltrating leukocytes. Administering SPMs into the inflamed site 4 hours after bacterial injection caused a reduction in PMN numbers over the ensuing 6 hours, the phase of active resolution in this model. These results indicate that in humans, the appearance of SPMs and their receptors is associated with the beginning of inflammatory resolution and that their therapeutic supplementation enhanced the resolution response.
- Published
- 2018
- Full Text
- View/download PDF
22. Bioactive Lipids and Chronic Inflammation: Managing the Fire Within.
- Author
-
Chiurchiù V, Leuti A, and Maccarrone M
- Subjects
- Autoimmune Diseases immunology, Autoimmune Diseases pathology, Humans, Inflammation pathology, Eicosanoids immunology, Endocannabinoids immunology, Glycerophospholipids immunology, Inflammation immunology, Inflammation Mediators immunology, Sphingolipids immunology
- Abstract
Inflammation is an immune response that works as a contained fire that is pre-emptively sparked as a defensive process during infections or upon any kind of tissue insult, and that is spontaneously extinguished after elimination or termination of the damage. However, persistent and uncontrolled immune reactions act as a wildfire that promote chronic inflammation, unresolved tissue damage and, eventually, chronic diseases. A wide network of soluble mediators, among which endogenous bioactive lipids, governs all immune processes. They are secreted by basically all cells involved in inflammatory processes and constitute the crucial infrastructure that triggers, coordinates and confines inflammatory mechanisms. However, these molecules are also deeply involved in the detrimental transition from acute to chronic inflammation, be it for persistent or excessive action of pro-inflammatory lipids or for the impairment of the functions carried out by resolving ones. As a matter of fact, bioactive lipids have been linked, to date, to several chronic diseases, including rheumatoid arthritis, atherosclerosis, diabetes, cancer, inflammatory bowel disease, systemic lupus erythematosus, and multiple sclerosis. This review summarizes current knowledge on the involvement of the main classes of endogenous bioactive lipids-namely classical eicosanoids, pro-resolving lipid mediators, lysoglycerophospholipids/sphingolipids, and endocannabinoids-in the cellular and molecular mechanisms that lead to the pathogenesis of chronic disorders.
- Published
- 2018
- Full Text
- View/download PDF
23. Host-based lipid inflammation drives pathogenesis in Francisella infection.
- Author
-
Scott AJ, Post JM, Lerner R, Ellis SR, Lieberman J, Shirey KA, Heeren RMA, Bindila L, and Ernst RK
- Subjects
- Animals, Cyclooxygenase 2 deficiency, Cyclooxygenase 2 genetics, Dinoprostone biosynthesis, Eicosanoids immunology, Eicosanoids metabolism, Endotoxins biosynthesis, Endotoxins toxicity, Female, Francisella physiology, Gene Expression, Gram-Negative Bacterial Infections metabolism, Gram-Negative Bacterial Infections mortality, Gram-Negative Bacterial Infections pathology, Immunity, Innate, Inflammation, Macrophages immunology, Macrophages metabolism, Macrophages pathology, Mass Spectrometry, Mice, Mice, Inbred C57BL, Mice, Knockout, Molecular Imaging, Phospholipids immunology, Phospholipids metabolism, Signal Transduction, Spleen metabolism, Spleen pathology, Survival Analysis, Cyclooxygenase 2 immunology, Dinoprostone immunology, Francisella pathogenicity, Gram-Negative Bacterial Infections immunology, Host-Pathogen Interactions, Spleen immunology
- Abstract
Mass spectrometry imaging (MSI) was used to elucidate host lipids involved in the inflammatory signaling pathway generated at the host-pathogen interface during a septic bacterial infection. Using Francisella novicida as a model organism, a bacterial lipid virulence factor (endotoxin) was imaged and identified along with host phospholipids involved in the splenic response in murine tissues. Here, we demonstrate detection and distribution of endotoxin in a lethal murine F. novicida infection model, in addition to determining the temporally and spatially resolved innate lipid inflammatory response in both 2D and 3D renderings using MSI. Further, we show that the cyclooxygenase-2-dependent lipid inflammatory pathway is responsible for lethality in F. novicida infection due to overproduction of proinflammatory effectors including prostaglandin E2. The results of this study emphasize that spatial determination of the host lipid components of the immune response is crucial to identifying novel strategies to effectively address highly pathogenic and lethal infections stemming from bacterial, fungal, and viral origins., Competing Interests: The authors declare no conflict of interest.
- Published
- 2017
- Full Text
- View/download PDF
24. Immune-regulation and -functions of eicosanoid lipid mediators.
- Author
-
Esser-von Bieren J
- Subjects
- Animals, Humans, Inflammation immunology, Prostaglandins immunology, Eicosanoids immunology
- Abstract
Bioactive lipids regulate most physiological processes, from digestion to blood flow and from hemostasis to labor. Lipid mediators are also involved in multiple pathologies including cancer, autoimmunity or asthma. The pathological roles of lipid mediators are based on their intricate involvement in the immune system, which comprises source and target cells of these mediators. Based on their biosynthetic origin, bioactive lipids can be grouped into different classes [e.g. sphingolipids, formed from sphingosine or eicosanoids, formed from arachidonic acid (AA)]. Owing to the complexity of different mediator classes and the prominent immunological roles of eicosanoids, this review will focus solely on the immune-regulation of eicosanoids. Eicosanoids do not only control key immune responses (e.g. chemotaxis, antigen presentation, phagocytosis), but they are also subject to reciprocal control by the immune system. Particularly, key immunoregulatory cytokines such as IL-4 and IFN-γ shape the cellular eicosanoid profile, thus providing efficient feedback regulation between cytokine and eicosanoid networks. For the purpose of this review, I will first provide a short overview of the most important immunological functions of eicosanoids with a focus on prostaglandins (PGs) and leukotrienes (LTs). Second, I will summarize the current knowledge on immunological factors that regulate eicosanoid production during infection and inflammation.
- Published
- 2017
- Full Text
- View/download PDF
25. Regulatory Functions of Phospholipase A2.
- Author
-
Murakami M, Nakatani Y, Atsumi GI, Inoue K, and Kudo I
- Subjects
- Animals, Arachidonic Acid immunology, Arachidonic Acid metabolism, Dietary Fats metabolism, Eicosanoids immunology, Eicosanoids metabolism, Gene Expression Regulation, Enzymologic immunology, Humans, Inflammation pathology, Isoenzymes genetics, Isoenzymes immunology, Isoenzymes metabolism, Lysophospholipids immunology, Lysophospholipids metabolism, Phospholipases A2, Calcium-Independent genetics, Phospholipases A2, Calcium-Independent immunology, Phospholipases A2, Cytosolic genetics, Phospholipases A2, Cytosolic immunology, Phospholipases A2, Secretory genetics, Phospholipases A2, Secretory immunology, Phospholipids immunology, Phospholipids metabolism, Protein Conformation, Receptors, Phospholipase A2 immunology, Signal Transduction immunology, Inflammation immunology, Phospholipases A2, Calcium-Independent metabolism, Phospholipases A2, Cytosolic metabolism, Phospholipases A2, Secretory metabolism, Receptors, Phospholipase A2 metabolism
- Abstract
Phospholipase A2 (PLA2) plays crucial roles in diverse cellular responses, including phospholipid digestion and metabolism, host defense and signal transduction. PLA2 provides precursors for generation of eicosanoids, such as prostaglandins (PGs) and leukotrienes (LTs), when the cleaved fatty acid is arachidonic acid, platelet-activating factor (PAF) when the sn-1 position of the phosphatidylcholine contains an alkyl ether linkage and some bioactive lysophospholipids, such as lysophosphatidic acid (lysoPA). As overproduction of these lipid mediators causes inflammation and tissue disorders, it is extremely important to understand the mechanisms regulating the expression and functions of PLA2. Recent advances in molecular and cellular biology have enabled us to understand the molecular nature, possible function, and regulation of a variety of PLA2 isozymes. Mammalian tissues and cells generally contain more than one enzyme, each of which is regulated independently and exerts distinct functions. Here we classify mammalian PLA2s into three large groups, namely, secretory (sPLA2), cytosolic (cPLA2), and Ca2+-independent PLA2s, on the basis of their enzymatic properties and structures and focus on the general undestanding of the possible regulatory functions of each PLA2 isozyme. In particular, the roles of type II sPLA2 and cPLA2 in lipid mediator generation are discussed.
- Published
- 2017
- Full Text
- View/download PDF
26. Mechanisms of the acute effects of inhaled ozone in humans.
- Author
-
Bromberg PA
- Subjects
- Administration, Inhalation, Alveolar Epithelial Cells immunology, Alveolar Epithelial Cells pathology, Cholesterol immunology, Cholesterol metabolism, Cytokines genetics, Cytokines immunology, Eicosanoids immunology, Eicosanoids metabolism, Gene Expression Regulation, Humans, Isoprostanes immunology, Isoprostanes metabolism, Lipid Peroxidation drug effects, Macrophages, Alveolar immunology, Macrophages, Alveolar pathology, NF-E2-Related Factor 2 genetics, NF-E2-Related Factor 2 immunology, Phospholipids immunology, Phospholipids metabolism, Pneumonia genetics, Pneumonia immunology, Pneumonia pathology, Respiratory System immunology, Respiratory System pathology, TRPM Cation Channels genetics, TRPM Cation Channels immunology, Toll-Like Receptor 4 genetics, Toll-Like Receptor 4 immunology, Alveolar Epithelial Cells drug effects, Macrophages, Alveolar drug effects, Ozone administration & dosage, Pneumonia chemically induced, Respiratory System drug effects
- Abstract
Ambient air ozone (O3) is generated photochemically from oxides of nitrogen and volatile hydrocarbons. Inhaled O3 causes remarkably reversible acute lung function changes and inflammation. Approximately 80% of inhaled O3 is deposited on the airways. O3 reacts rapidly with CC double bonds in hydrophobic airway and alveolar surfactant-associated phospholipids and cholesterol. Resultant primary ozonides further react to generate bioactive hydrophilic products that also initiate lipid peroxidation leading to eicosanoids and isoprostanes of varying electrophilicity. Airway surface liquid ascorbate and urate also scavenge O3. Thus, inhaled O3 may not interact directly with epithelial cells. Acute O3-induced lung function changes are dominated by involuntary inhibition of inspiration (rather than bronchoconstriction), mediated by stimulation of intraepithelial nociceptive vagal C-fibers via activation of transient receptor potential (TRP) A1 cation channels by electrophile (e.g., 4-oxo-nonenal) adduction of TRPA1 thiolates enhanced by PGE2-stimulated sensitization. Acute O3-induced neutrophilic airways inflammation develops more slowly than the lung function changes. Surface macrophages and epithelial cells are involved in the activation of epithelial NFkB and generation of proinflammatory mediators such as IL-6, IL-8, TNFa, IL-1b, ICAM-1, E-selectin and PGE2. O3-induced partial depolymerization of hyaluronic acid and the release of peroxiredoxin-1 activate macrophage TLR4 while oxidative epithelial cell release of EGFR ligands such as TGFa or EGFR transactivation by activated Src may also be involved. The ability of lipid ozonation to generate potent electrophiles also provides pathways for Nrf2 activation and inhibition of canonical NFkB activation. This article is part of a Special Issue entitled Air Pollution, edited by Wenjun Ding, Andrew J. Ghio and Weidong Wu., (Copyright © 2016. Published by Elsevier B.V.)
- Published
- 2016
- Full Text
- View/download PDF
27. Liberating Chiral Lipid Mediators, Inflammatory Enzymes, and LIPID MAPS from Biological Grease.
- Author
-
Dennis EA
- Subjects
- Animals, Eicosanoids immunology, Humans, Phospholipases A2 immunology, Eicosanoids metabolism, Inflammation Mediators metabolism, Phospholipases A2 metabolism, Signal Transduction
- Abstract
In 1970, it was well accepted that the central role of lipids was in energy storage and metabolism, and it was assumed that amphipathic lipids simply served a passive structural role as the backbone of biological membranes. As a result, the scientific community was focused on nucleic acids, proteins, and carbohydrates as information-containing molecules. It took considerable effort until scientists accepted that lipids also "encode" specific and unique biological information and play a central role in cell signaling. Along with this realization came the recognition that the enzymes that act on lipid substrates residing in or on membranes and micelles must also have important signaling roles, spurring curiosity into their potentially unique modes of action differing from those acting on water-soluble substrates. This led to the creation of the concept of "surface dilution kinetics" for describing the mechanism of enzymes acting on lipid substrates, as well as the demonstration that lipid enzymes such as phospholipase A
2 (PLA2 ) contain allosteric activator sites for specific phospholipids as well as for membranes. As our understanding of phospholipases advanced, so did the understanding that many of the lipids released by these enzymes are chiral information-containing signaling molecules; for example, PLA2 regulates the generation of precursors for the biosynthesis of eicosanoids and other bioactive lipid mediators of inflammation and resolution underlying disease progression. The creation of the LIPID MAPS initiative in 2003 and the ensuing development of the lipidomics field have revealed that lipid metabolites are central to human metabolism. Today lipids are recognized as key mediators of health and disease as we enter a new era of biomarkers and personalized medicine. This article is my personal "reflection" on these scientific advances., (© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.)- Published
- 2016
- Full Text
- View/download PDF
28. Inflammatory signaling in human tuberculosis granulomas is spatially organized.
- Author
-
Marakalala MJ, Raju RM, Sharma K, Zhang YJ, Eugenin EA, Prideaux B, Daudelin IB, Chen PY, Booty MG, Kim JH, Eum SY, Via LE, Behar SM, Barry CE 3rd, Mann M, Dartois V, and Rubin EJ
- Subjects
- Animals, Arachidonic Acid metabolism, Eicosanoids metabolism, Granuloma metabolism, Granuloma pathology, Humans, Immunohistochemistry, Inflammation metabolism, Inflammation pathology, Laser Capture Microdissection, Mass Spectrometry, Microscopy, Confocal, Proteomics, Rabbits, Reactive Oxygen Species metabolism, Signal Transduction, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Tuberculosis, Pulmonary metabolism, Tuberculosis, Pulmonary pathology, Eicosanoids immunology, Granuloma immunology, Inflammation immunology, Reactive Oxygen Species immunology, Tuberculosis, Pulmonary immunology
- Abstract
Granulomas are the pathological hallmark of tuberculosis (TB). However, their function and mechanisms of formation remain poorly understood. To understand the role of granulomas in TB, we analyzed the proteomes of granulomas from subjects with tuberculosis in an unbiased manner. Using laser-capture microdissection, mass spectrometry and confocal microscopy, we generated detailed molecular maps of human granulomas. We found that the centers of granulomas have a pro-inflammatory environment that is characterized by the presence of antimicrobial peptides, reactive oxygen species and pro-inflammatory eicosanoids. Conversely, the tissue surrounding the caseum has a comparatively anti-inflammatory signature. These findings are consistent across a set of six human subjects and in rabbits. Although the balance between systemic pro- and anti-inflammatory signals is crucial to TB disease outcome, here we find that these signals are physically segregated within each granuloma. From the protein and lipid snapshots of human and rabbit lesions analyzed here, we hypothesize that the pathologic response to TB is shaped by the precise anatomical localization of these inflammatory pathways during the development of the granuloma.
- Published
- 2016
- Full Text
- View/download PDF
29. UPLC-MS/MS-Based Profiling of Eicosanoids in RAW264.7 Cells Treated with Lipopolysaccharide.
- Author
-
Lee JW, Mok HJ, Lee DY, Park SC, Ban MS, Choi J, Park CG, Ahn YS, Kim KP, and Kim HD
- Subjects
- Animals, Chromatography, High Pressure Liquid methods, Eicosanoids analysis, Inflammation immunology, Interleukin-6 analysis, Interleukin-6 immunology, Macrophages chemistry, Mice, Nitric Oxide analysis, Nitric Oxide immunology, RAW 264.7 Cells, Tandem Mass Spectrometry methods, Tumor Necrosis Factor-alpha analysis, Tumor Necrosis Factor-alpha immunology, Eicosanoids immunology, Lipopolysaccharides immunology, Macrophages immunology
- Abstract
While both the pro- and anti-inflammatory effects of several eicosanoids have been widely studied, the degree of inflammation in cells that results from various eicosanoids has yet to be comprehensively studied. The objective of this study was to assess the effect of lipopolysaccharide (LPS) treatment on eicosanoid content in RAW264.7 cells. An Ultra performance liquid chromatography coupled to tandem mass spectrometry (UPLC-MS/MS)-based profiling method was used to analyze the eicosanoid contents of RAW264.7 cells treated with different LPS concentrations. The profiling data were subjected to statistical analyses, such as principal component analysis (PCA) and hierarchical clustering analysis. LPS treatment increased nitric oxide production and secretion of pro-inflammatory cytokines, such as tumor necrosis factor-α and interleukin-6, in a concentration-dependent manner. In total, 79 eicosanoids were identified in the cells. RAW264.7 cells treated with different LPS concentrations were well differentiated in the PCA score plot. A heatmap was used to identify the eicosanoids that were up- or down-regulated according to the degree of inflammation and LPS concentration. Thirty-nine eicosanoids were upregulated and seven were down-regulated by LPS treatment in a concentration-dependent manner. Our novel UPLC-MS/MS technique can profile eicosanoids, and can evaluate the correlations between inflammation and eicosanoid metabolism.
- Published
- 2016
- Full Text
- View/download PDF
30. Eicosanoids mediate Galleria mellonella immune response to hemocoel injection of entomopathogenic nematode cuticles.
- Author
-
Yi Y, Wu G, Lv J, and Li M
- Subjects
- Animals, Eicosanoids biosynthesis, Hemocytes cytology, Hemocytes immunology, Hemolymph immunology, Host-Parasite Interactions immunology, Immunity, Innate, Larva immunology, Microspheres, Phagocytosis, Rhabditida microbiology, Rhabditoidea immunology, Rhabditoidea microbiology, Symbiosis, Eicosanoids immunology, Moths immunology, Rhabditida immunology
- Abstract
Entomopathogenic nematodes are symbiotically associated with bacteria and widely used in biological control of insect pests. The interference of symbiotic bacteria with insect host immune responses is fairly well documented. However, knowledge of mechanisms regulating parasite–host interactions still remains fragmentary. In this study, we used nematode (Steinernema carpocapsae and Heterorhabditis bacteriophora) cuticles and Galleria mellonella larvae as parasite–host model, focused on the changes of innate immune parameters of the host in the early phase of nematode cuticle infection and investigated the role of eicosanoid biosynthesis pathway in the process. The results showed that injection of either S. carpocapsae or H. bacteriophora cuticles into the larval hemocoel both resulted in significant decreases in the key innate immune parameters (e.g., hemocyte density, microaggregation, phagocytosis and encapsulation abilities of hemocyte, and phenoloxidase and antibacterial activities of the cell-free hemolymph). Our study indicated that the parasite cuticles could actively suppress the innate immune response of the G. mellonella host. We also found that treating G. mellonella larvae with dexamethasone and indomethacin induced similar depression in the key innate immune parameters to the nematode cuticles. However, these effects were reversed when dexamethasone, indomethacin, or nematode cuticles were injected together with arachidonic acid. Additionally, we found that palmitic acid did not reverse the influence of the dexamethasone, indomethacin, or nematode cuticles on the innate immune responses. Therefore, we inferred from our results that both S. carpocapsae and H. bacteriophora cuticles inhibited eicosanoid biosynthesis to induce host immunodepression.
- Published
- 2016
- Full Text
- View/download PDF
31. Pilot clinical study of the effects of ginger root extract on eicosanoids in colonic mucosa of subjects at increased risk for colorectal cancer.
- Author
-
Zick SM, Turgeon DK, Ren J, Ruffin MT, Wright BD, Sen A, Djuric Z, and Brenner DE
- Subjects
- Adult, Aged, Anti-Inflammatory Agents chemistry, Anti-Inflammatory Agents immunology, Anticarcinogenic Agents chemistry, Anticarcinogenic Agents immunology, Anticarcinogenic Agents therapeutic use, Colon drug effects, Colon immunology, Colon pathology, Colorectal Neoplasms pathology, Eicosanoids analysis, Female, Humans, Intestinal Mucosa immunology, Intestinal Mucosa pathology, Male, Middle Aged, Pilot Projects, Plant Extracts adverse effects, Plant Extracts chemistry, Plant Extracts immunology, Rectum drug effects, Rectum immunology, Rectum pathology, Anti-Inflammatory Agents therapeutic use, Colorectal Neoplasms immunology, Colorectal Neoplasms prevention & control, Eicosanoids immunology, Zingiber officinale chemistry, Intestinal Mucosa drug effects, Plant Extracts therapeutic use
- Abstract
Colorectal cancer (CRC) remains a significant cause of mortality. Inhibitors of cyclooxygenase (COX) and thus prostaglandin E2, are promising CRC preventives, but have significant toxicities. Ginger has been shown to inhibit COX, to decrease the incidence and multiplicity of adenomas, and decrease PGE2 concentrations in subjects at normal risk for CRC. This study was conducted to determine the effects of 2.0 g/d of ginger given orally on the levels of PGE2, leukotriene B4 (LTB4), 13-hydroxy-octadecadienoic acids, and 5-, 12-, & 15-hydroxyeicosatetraenoic acid, in the colonic mucosa of subjects at increased risk for CRC. We randomized 20 subjects to 2.0 g/d ginger or placebo for 28 d. At baseline and Day 28, a flexible sigmoidoscopy was used to obtain colon biopsies. A liquid chromatography mass spectrometry method was used to determine eicosanoid levels in the biopsies, and levels were expressed per amount of protein or free arachidonic acid (AA). There was a significant decrease in AA between baseline and Day 28 (P = 0.05) and significant increase in LTB4 (P = 0.04) when normalized to protein, in subjects treated with ginger versus placebo. No other changes in eicosanoids were observed. There was no difference between the groups in total adverse events (AE; P = 0.06). Ginger lacks the ability to decrease eicosanoid levels in people at increased risk for CRC. Ginger did appear to be both tolerable and safe; and could have chemopreventive effects through other mechanisms. Further investigation should focus on other markers of CRC risk in those at increased CRC risk., (© 2014 Wiley Periodicals, Inc.)
- Published
- 2015
- Full Text
- View/download PDF
32. Eicosanoid storm in infection and inflammation.
- Author
-
Dennis EA and Norris PC
- Subjects
- Animals, Bacterial Infections genetics, Bacterial Infections microbiology, Bacterial Infections pathology, Cytochrome P-450 Enzyme System genetics, Cytochrome P-450 Enzyme System immunology, Cytokines immunology, Cytokines metabolism, Eicosanoids biosynthesis, Gene Expression Regulation, Humans, Inflammation genetics, Inflammation immunology, Inflammation pathology, Inflammation Mediators metabolism, Phospholipases genetics, Phospholipases immunology, Prostaglandin-Endoperoxide Synthases genetics, Prostaglandin-Endoperoxide Synthases immunology, Signal Transduction, Bacterial Infections immunology, Eicosanoids immunology, Immunity, Innate, Inflammation Mediators immunology, Lipid Metabolism immunology
- Abstract
Controlled immune responses to infection and injury involve complex molecular signalling networks with coordinated and often opposing actions. Eicosanoids and related bioactive lipid mediators derived from polyunsaturated fatty acids constitute a major bioactive lipid network that is among the most complex and challenging pathways to map in a physiological context. Eicosanoid signalling, similar to cytokine signalling and inflammasome formation, has primarily been viewed as a pro-inflammatory component of the innate immune response; however, recent advances in lipidomics have helped to elucidate unique eicosanoids and related docosanoids with anti-inflammatory and pro-resolution functions. This has advanced our overall understanding of the inflammatory response and its therapeutic implications. The induction of a pro-inflammatory and anti-inflammatory eicosanoid storm through the activation of inflammatory receptors by infectious agents is reviewed here.
- Published
- 2015
- Full Text
- View/download PDF
33. The Etiology and Pathogenesis of Chronic Rhinosinusitis: a Review of Current Hypotheses.
- Author
-
Lam K, Schleimer R, and Kern RC
- Subjects
- Animals, Biofilms, Chronic Disease, Eicosanoids immunology, Humans, Microbiota, Rhinitis immunology, Sinusitis immunology
- Abstract
Chronic rhinosinusitis (CRS) is a broad clinical syndrome that is characterized by prolonged mucosal inflammation of the nose and paranasal sinuses, and is typically divided into two subtypes based on the presence or absence of nasal polyps. The etiology and pathogenesis of both forms remain areas of active research. Over the last 15 years, a number of hypotheses have been proposed to explain all or part of the clinical CRS spectrum. These hypotheses reflect the concept that CRS results from a dysfunctional interplay between individual host characteristics and factors exogenous to the host. Six broad theories on CRS etiology and pathogenesis are discussed as follows: (1) the "fungal hypothesis," (2) the "superantigen hypothesis," (3) the "biofilm hypothesis," and (4) the "microbiome hypothesis," all of which emphasize key environmental factors, and (5) the "eicosanoid hypothesis" and (6) the "immune barrier hypothesis," which describe specific host factors. These theories are reviewed, and the evidence supporting them is critically appraised.
- Published
- 2015
- Full Text
- View/download PDF
34. Host-Directed Therapies for Tuberculosis.
- Author
-
Tobin DM
- Subjects
- Animals, Anti-Inflammatory Agents immunology, Anti-Inflammatory Agents pharmacology, Autophagy drug effects, Autophagy immunology, Cells, Cultured, Clinical Trials as Topic, Disease Models, Animal, Drug Evaluation, Preclinical, Eicosanoids immunology, Host-Pathogen Interactions immunology, Humans, Immunity, Cellular drug effects, Immunologic Factors immunology, Inflammation immunology, Inflammation prevention & control, Lipid Metabolism drug effects, Lipid Metabolism immunology, Matrix Metalloproteinases drug effects, Matrix Metalloproteinases immunology, Mycobacterium tuberculosis immunology, Neutrophils immunology, Phosphodiesterase Inhibitors immunology, Phosphodiesterase Inhibitors pharmacology, Protein Kinases drug effects, Protein Kinases immunology, Tuberculosis immunology, Vitamin D immunology, Vitamin D pharmacology, Immunologic Factors pharmacology, Immunotherapy methods, Tuberculosis therapy
- Abstract
Host-directed therapies are a relatively new and promising approach to treatment of tuberculosis. Modulation of specific host immune pathways, including those that impact inflammation and immunopathology, can limit mycobacterial infection and pathology, both in cell culture and in animal models. This review explores a range of host pathways and drugs, some already approved for clinical use that have the potential to provide new adjunctive therapies for tuberculosis. Drugs targeting host processes may largely avoid the development of bacterial antibiotic resistance, a major public health concern for tuberculosis. However, these drugs may also have generally increased risk for side effects on the host. Understanding the specific mechanisms by which these drugs act and the relationship of these mechanisms to Mycobacterium tuberculosis pathogenesis will be critical in selecting appropriate host-directed therapy. Overall, these host-directed compounds provide a novel strategy for antituberculosis therapy., (Copyright © 2015 Cold Spring Harbor Laboratory Press; all rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
35. Eicosanoids mediate sHSP 20.8 gene response to biotic stress in larvae of the Chinese oak silkworm Antheraea pernyi.
- Author
-
Zhang CF, Dai LS, Wang L, Qian C, Wei GQ, Li J, Zhu BJ, and Liu CL
- Subjects
- Amino Acid Sequence, Animals, Botrytis immunology, Eicosanoids immunology, Eicosanoids pharmacology, Escherichia coli immunology, Fat Body drug effects, Fat Body immunology, Fat Body metabolism, Fat Body microbiology, Gene Expression Regulation, Developmental, Heat-Shock Proteins, Small immunology, Insect Proteins immunology, Intestinal Mucosa metabolism, Intestines drug effects, Intestines immunology, Intestines microbiology, Isoelectric Point, Larva drug effects, Larva genetics, Larva growth & development, Larva immunology, Molecular Sequence Data, Moths drug effects, Moths growth & development, Moths immunology, Nucleopolyhedroviruses immunology, Open Reading Frames, Sequence Homology, Amino Acid, Stress, Physiological, Heat-Shock Proteins, Small genetics, Insect Proteins genetics, Moths genetics
- Abstract
Small heat shock proteins (sHSPs) can regulate protein folding and protect cells from stress. To investigate the role of sHSPs in the silk-producing insect Antheraea pernyi (A. pernyi; Lepidoptera: Saturniidae), cDNA encoding HSP20.8 in A. pernyi, termed Ap-sHSP20.8, was identified as a 564 bp ORF. The translated amino acid sequence encoded 187 residues with a calculated molecular mass of 20.8 kDa and an isoelectronic point (pI) of 5.98; the sequence showed homology to sHSP chaperone proteins from other insects. Ap-sHSP20.8 mRNA transcript expression was abundant in the midgut and fat body and found to be both constitutive and inducible by infectious stimuli. Therefore, Ap-sHSP20.8 may play important roles in A. pernyi immune responses under biotic stress. Furthermore, we found that eicosanoids could mediate the induction of Ap-sHSP20.8 in the fat body and midgut. Our findings show that sHSPs may be promising molecules to target in order to cripple immunity in insect pests., (Copyright © 2014 Elsevier B.V. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
36. Prostaglandin D₂: a dominant mediator of aspirin-exacerbated respiratory disease.
- Author
-
Cahill KN, Bensko JC, Boyce JA, and Laidlaw TM
- Subjects
- Adult, Aspirin immunology, Basophils, Desensitization, Immunologic, Drug Hypersensitivity etiology, Drug Hypersensitivity immunology, Drug Hypersensitivity therapy, Eicosanoids urine, Eosinophils, Female, Humans, Leukocyte Count, Male, Middle Aged, Respiratory Tract Diseases urine, Aspirin adverse effects, Eicosanoids immunology, Respiratory Tract Diseases chemically induced, Respiratory Tract Diseases immunology
- Abstract
Background: Aspirin desensitization followed by high-dose aspirin therapy is routinely performed for patients with aspirin-exacerbated respiratory disease (AERD). Little is known about the contributions of mediators other than cysteinyl leukotrienes to aspirin reactions and to the therapeutic benefit of high-dose aspirin therapy., Objective: We investigated differences in urinary eicosanoid metabolite levels and blood eosinophil counts in patients with AERD who tolerate and those who fail aspirin desensitization and also in patients with AERD who were successfully treated with high-dose aspirin therapy., Methods: Twenty-nine patients with AERD were stratified into those who tolerated aspirin desensitization (group I) and those who did not (group II). Urine was analyzed for eicosanoid metabolites at baseline, during aspirin reactions, and during high-dose aspirin therapy. Blood was analyzed for cell differentials at baseline and during aspirin therapy., Results: Basal prostaglandin D2 metabolite (PGD-M; 13.6 ± 2.7 vs 7.0 ± 0.8 pmol/mg creatinine [Cr], P < .05) and thromboxane metabolite (TX-M; 1.4 ± 0.3 vs 0.9 ± 0.1 pmol/mg Cr, P < .01) levels were higher in group II than in group I. During aspirin reactions, PGD-M levels remained unchanged, whereas TX-M levels (0.7 ± 0.1 pmol/mg Cr, P = .07) tended to decrease in group I. In contrast, PGD-M levels increased dramatically in group II (61.3 ± 19.9 pmol/mg Cr, P < .05), whereas TX-M levels did not change. The decrease in FEV1 inversely correlated with basal urinary levels of both leukotriene E4 and PGD-M. Blood eosinophil and basophil levels increased and urinary PGD-M levels (2.2 ± 0.8 pmol/mg Cr, P < .001) decreased on 2 months of high-dose aspirin therapy in group I., Conclusion: Failure to tolerate aspirin desensitization in a subset of patients with AERD is associated with prostaglandin D2 overproduction. The increase in blood eosinophil and basophil counts during high-dose aspirin therapy might reflect the functional consequences of decreased prostaglandin D2 release and the therapeutic benefit of aspirin., (Copyright © 2014 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
37. Phospholipid remodeling and eicosanoid signaling in colon cancer cells.
- Author
-
Das S, Martinez LR, and Ray S
- Subjects
- Animals, Colonic Neoplasms genetics, Colonic Neoplasms immunology, Humans, Models, Immunological, Colonic Neoplasms metabolism, Eicosanoids immunology, Gene Expression Regulation, Neoplastic immunology, Neoplasm Proteins immunology, Oxygenases immunology, Phospholipids immunology, Signal Transduction immunology
- Abstract
Phospholipid remodeling and eicosanoid synthesis are central to lipid-based inflammatory reactions. Studies have revealed that membrane phospholipid remodeling by fatty acids through deacylation/reacylation reactions increases the risk of colorectal cancers (CRC) by allowing the cells to produce excess inflammatory eicosanoids, such as prostaglandins, thromboxanes and leukotrienes. Over the years, efforts have been made to understand the lipid remodeling pathways and to design anti-cancer drugs targeting the enzymes of eicosanoid biosynthesis. Here, we discuss the recent progress in phospholipid remodeling and eicosanoid biosynthesis in CRC.
- Published
- 2014
38. Phospholipase A2 regulates eicosanoid class switching during inflammasome activation.
- Author
-
Norris PC, Gosselin D, Reichart D, Glass CK, and Dennis EA
- Subjects
- Animals, Aspirin pharmacology, Celecoxib, Cell Line, Transformed, Cyclooxygenase 2 Inhibitors pharmacology, Cyclooxygenase Inhibitors pharmacology, Eicosanoids immunology, Group IV Phospholipases A2 immunology, Hydroxyeicosatetraenoic Acids immunology, Hydroxyeicosatetraenoic Acids metabolism, Inflammasomes immunology, Interleukin-1 immunology, Interleukin-1 metabolism, Lipidoses immunology, Macrophages cytology, Macrophages immunology, Male, Mice, Mice, Inbred C57BL, Pyrazoles pharmacology, Receptors, Purinergic P2X7 immunology, Receptors, Purinergic P2X7 metabolism, Sulfonamides pharmacology, Toll-Like Receptor 4 immunology, Toll-Like Receptor 4 metabolism, Eicosanoids metabolism, Group IV Phospholipases A2 metabolism, Inflammasomes metabolism, Macrophages enzymology, Signal Transduction immunology
- Abstract
Initiation and resolution of inflammation are considered to be tightly connected processes. Lipoxins (LX) are proresolution lipid mediators that inhibit phlogistic neutrophil recruitment and promote wound-healing macrophage recruitment in humans via potent and specific signaling through the LXA4 receptor (ALX). One model of lipoxin biosynthesis involves sequential metabolism of arachidonic acid by two cell types expressing a combined transcellular metabolon. It is currently unclear how lipoxins are efficiently formed from precursors or if they are directly generated after receptor-mediated inflammatory commitment. Here, we provide evidence for a pathway by which lipoxins are generated in macrophages as a consequence of sequential activation of toll-like receptor 4 (TLR4), a receptor for endotoxin, and P2X7, a purinergic receptor for extracellular ATP. Initial activation of TLR4 results in accumulation of the cyclooxygenase-2-derived lipoxin precursor 15-hydroxyeicosatetraenoic acid (15-HETE) in esterified form within membrane phospholipids, which can be enhanced by aspirin (ASA) treatment. Subsequent activation of P2X7 results in efficient hydrolysis of 15-HETE from membrane phospholipids by group IVA cytosolic phospholipase A2, and its conversion to bioactive lipoxins by 5-lipoxygenase. Our results demonstrate how a single immune cell can store a proresolving lipid precursor and then release it for bioactive maturation and secretion, conceptually similar to the production and inflammasome-dependent maturation of the proinflammatory IL-1 family cytokines. These findings provide evidence for receptor-specific and combinatorial control of pro- and anti-inflammatory eicosanoid biosynthesis, and potential avenues to modulate inflammatory indices without inhibiting downstream eicosanoid pathways.
- Published
- 2014
- Full Text
- View/download PDF
39. A lipidomic perspective on inflammatory macrophage eicosanoid signaling.
- Author
-
Norris PC and Dennis EA
- Subjects
- Animals, Eicosanoids immunology, Humans, Lipids immunology, Macrophages immunology, Signal Transduction, Eicosanoids chemistry, Lipids chemistry, Macrophages chemistry
- Abstract
Macrophages are central to essential physiological processes including the regulation of innate and adaptive immunity, but they are also central to a number of inflammatory disease states. These immune cells also possess remarkable plasticity and display various shades of functionalities based on changes in the surrounding molecular environment. Macrophage biology has defined various phenotypes and roles in inflammation based primarily on cytokine and chemokine profiles of cells in different activation states. Importantly, macrophages are elite producers of eicosanoids and other related lipid mediators during inflammation, but specific roles of these molecules have not generally been incorporated into the larger context of macrophage biology. In this review, we discuss the current classification of macrophage types and their roles in inflammation and disease, along with the practical challenges of studying biologically relevant phenotypes ex vivo. Using the latest advances in eicosanoid lipidomics, we highlight several key studies from our laboratory that provide a comprehensive understanding of how eicosanoid metabolism differs between macrophage phenotypes, along with how this metabolism is altered by changes in membrane fatty acid distribution and varied durations of Toll-like receptor (TLR) priming. In conclusion, we summarize several examples of the benefit of macrophage plasticity to develop accurate cellular mechanisms of lipid metabolism, and insights from lipidomic analyses about the differences in eicosanoid pathway enzyme activity in vitro vs. in cells ex vivo. Examples of new techniques to further understand the role of macrophage eicosanoid signaling in vivo are also discussed., (Copyright © 2013 Elsevier Ltd. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
40. Natural resolution of inflammation.
- Author
-
Freire MO and Van Dyke TE
- Subjects
- Docosahexaenoic Acids immunology, Eicosanoids immunology, Homeostasis immunology, Humans, Immunity, Innate immunology, Inflammation immunology, Leukocytes classification, Leukocytes immunology, Leukotrienes immunology, Lipids immunology, Lipoxins immunology, Prostaglandins immunology, Inflammation Mediators immunology, Periodontitis immunology
- Abstract
Inflammation is a protective response essential for maintaining human health and for fighting disease. As an active innate immune reaction to challenge, inflammation gives rise to clinical cardinal signs: rubor, calor, dolor, tumor and functio laesa. Termination of acute inflammation was previously recognized as a passive process; a natural decay of pro-inflammatory signals. We now understand that the natural resolution of inflammation involves well-integrated, active, biochemical programs that return tissues to homeostasis. This review focuses on recent advances in the understanding of the role of endogenous lipid mediators that modulate cellular fate and inflammation. Biosynthesis of eicosanoids and other lipids in exudates coincides with changes in the types of inflammatory cells. Resolution of inflammation is initiated by an active class switch in lipid mediators, such as classic prostaglandins and leukotrienes, to the production of proresolution mediators. Endogenous pro-resolving lipid mediators, including arachidonic acid-derived lipoxins, aspirin-triggered lipoxins, ω3-eicosapentaenoic acid-derived resolvins of the E-series, docosahexaenoic acid-derived resolvins of the D-series, protectins and maresins, are biosynthesized during the resolution phase of acute inflammation. Depending on the type of injury and the type of tissue, the initial cells that respond are polymorphonuclear leukocytes, monocytes/macrophages, epithelial cells or endothelial cells. The selective interaction of specific lipid mediators with G protein-coupled receptors expressed on innate immune cells (e.g. G protein-coupled receptor 32, lipoxin A4 receptor/formyl peptide receptor2, chemokine-like receptor 1, leukotriene B4 receptor type 1 and cabannoid receptor 2) induces cessation of leukocyte infiltration; vascular permeability/edema returns to normal with polymorphonuclear neutrophil death (mostly via apoptosis), the nonphlogistic infiltration of monocyte/macrophages and the removal (by macrophages) of apoptotic polymorphonuclear neutrophils, foreign agents (bacteria) and necrotic debris from the site. While an acute inflammatory response that is resolved in a timely manner prevents tissue injury, inadequate resolution and failure to return tissue to homeostasis results in neutrophil-mediated destruction and chronic inflammation. A better understanding of the complex mechanisms of lipid agonist mediators, cell targets and actions allows us to exploit and develop novel therapeutic strategies to treat human inflammatory diseases, including periodontal diseases., (© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)
- Published
- 2013
- Full Text
- View/download PDF
41. Lipidomic profiling of influenza infection identifies mediators that induce and resolve inflammation.
- Author
-
Tam VC, Quehenberger O, Oshansky CM, Suen R, Armando AM, Treuting PM, Thomas PG, Dennis EA, and Aderem A
- Subjects
- Animals, Arachidonate 5-Lipoxygenase metabolism, Cytokines immunology, Disease Models, Animal, Eicosanoids immunology, Fatty Acids, Unsaturated immunology, Humans, Inflammation Mediators analysis, Metabolic Networks and Pathways, Mice, Nasal Lavage Fluid immunology, Transcriptome, Eicosanoids isolation & purification, Fatty Acids, Unsaturated isolation & purification, Influenza A Virus, H1N1 Subtype physiology, Influenza A Virus, H3N2 Subtype physiology, Influenza, Human immunology, Lipids analysis, Orthomyxoviridae Infections immunology
- Abstract
Bioactive lipid mediators play a crucial role in the induction and resolution of inflammation. To elucidate their involvement during influenza infection, liquid chromatography/mass spectrometry lipidomic profiling of 141 lipid species was performed on a mouse influenza model using two viruses of significantly different pathogenicity. Infection by the low-pathogenicity strain X31/H3N2 induced a proinflammatory response followed by a distinct anti-inflammatory response; infection by the high-pathogenicity strain PR8/H1N1 resulted in overlapping pro- and anti-inflammatory states. Integration of the large-scale lipid measurements with targeted gene expression data demonstrated that 5-lipoxygenase metabolites correlated with the pathogenic phase of the infection, whereas 12/15-lipoxygenase metabolites were associated with the resolution phase. Hydroxylated linoleic acid, specifically the ratio of 13- to 9-hydroxyoctadecadienoic acid, was identified as a potential biomarker for immune status during an active infection. Importantly, some of the findings from the animal model were recapitulated in studies of human nasopharyngeal lavages obtained during the 2009-2011 influenza seasons., (Copyright © 2013 Elsevier Inc. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
42. Cyclooxygenase-2 inhibits T helper cell type 9 differentiation during allergic lung inflammation via down-regulation of IL-17RB.
- Author
-
Li H, Edin ML, Bradbury JA, Graves JP, DeGraff LM, Gruzdev A, Cheng J, Dackor RT, Wang PM, Bortner CD, Garantziotis S, Jetten AM, and Zeldin DC
- Subjects
- Animals, Cytokines analysis, Eicosanoids immunology, Eicosanoids physiology, Flow Cytometry, Humans, Immunoblotting, Inflammation immunology, Male, Mice, Microscopy, Confocal, Models, Animal, Real-Time Polymerase Chain Reaction, Asthma immunology, Cyclooxygenase 2 Inhibitors immunology, Lung immunology, Receptors, Interleukin-17 immunology, T-Lymphocyte Subsets immunology
- Abstract
Rationale: Helper CD4(+) T cell subsets, including IL-9- and IL-10-producing T helper cell type 9 (Th9) cells, exist under certain inflammatory conditions. Cyclooxygenase (COX)-1 and COX-2 play important roles in allergic lung inflammation and asthma. It is unknown whether COX-derived eicosanoids regulate Th9 cells during allergic lung inflammation., Objectives: To determine the role of COX metabolites in regulating Th9 cell differentiation and function during allergic lung inflammation., Methods: COX-1(-/-), COX-2(-/-), and wild-type (WT) mice were studied in an in vivo model of ovalbumin-induced allergic inflammation and an in vitro model of Th9 differentiation using flow cytometry, cytokine assays, confocal microscopy, real-time PCR, and immunoblotting. In addition, the role of specific eicosanoids and their receptors was examined using synthetic prostaglandins (PGs), selective inhibitors, and siRNA knockdown., Measurements and Main Results: Experimental endpoints were not different between COX-1(-/-) and WT mice; however, the percentage of IL-9(+) CD4(+) T cells was increased in lung, bronchoalveolar lavage fluid, lymph nodes, and blood of allergic COX-2(-/-) mice relative to WT. Bronchoalveolar lavage fluid IL-9 and IL-10, serum IL-9, and lung IL-17RB levels were significantly increased in allergic COX-2(-/-) mice or in WT mice treated with COX-2 inhibitors. IL-9, IL-10, and IL-17RB expression in vivo was inhibited by PGD2 and PGE2, which also reduced Th9 cell differentiation of murine and human naive CD4(+) T cells in vitro. Inhibition of protein kinase A significantly increased Th9 cell differentiation of naive CD4(+) T cells isolated from WT mice in vitro., Conclusions: COX-2-derived PGD2 and PGE2 regulate Th9 cell differentiation by suppressing IL-17RB expression via a protein kinase A-dependent mechanism.
- Published
- 2013
- Full Text
- View/download PDF
43. CD4+ T lymphocytes in lung fibrosis: diverse subsets, diverse functions.
- Author
-
Lo Re S, Lison D, and Huaux F
- Subjects
- Acute Disease, Animals, Bronchi immunology, Bronchi physiopathology, CD4-Positive T-Lymphocytes immunology, Cytokines immunology, Eicosanoids immunology, Epithelial Cells immunology, Epithelial Cells pathology, Fibroblasts immunology, Fibroblasts pathology, Humans, Intercellular Signaling Peptides and Proteins immunology, Mice, Pulmonary Alveoli immunology, Pulmonary Alveoli physiopathology, Pulmonary Fibrosis immunology, Pulmonary Fibrosis physiopathology, T-Lymphocyte Subsets immunology, CD4-Positive T-Lymphocytes pathology, Pulmonary Fibrosis pathology, T-Lymphocyte Subsets pathology
- Abstract
The discovery of several subsets of CD4(+) Th lymphocytes has contributed to refine and to challenge our understanding of the roles of CD4(+) T cells in the pathogenesis of fibrotic lung diseases. Here, we review recent findings, indicating that CD4(+) T subpopulations possess contrasting pro- and antifibrotic activities in human and experimental lung fibrosis. Special attention is given to delineate the activity of the newly discovered CD4(+) T lymphocyte subsets (Tregs, Th22, and Th9) on fibroblast function and matrix deposition through the release of growth factors, cytokines, and eicosanoids. It appears that the function of a CD4(+) T lymphocyte subset or of a cytokine can differ with the disease stage (acute vs. chronic), pulmonary localization (bronchial vs. alveolar), cellular level (epithelial cell vs. fibroblast), or immune environment (inflammatory or immunosuppressive). Integrating our recent understanding of the contrasting functions of T lymphocyte subsets in fibrosis provides new insights and opportunities for improved treatment strategies.
- Published
- 2013
- Full Text
- View/download PDF
44. Eicosanoid imbalance correlates in vitro with the pattern of clinical symptoms of Samter's triad.
- Author
-
Forster U, Strathmann S, Schafer D, Szczepek AJ, and Olze H
- Subjects
- Adult, Aged, Anti-Inflammatory Agents, Non-Steroidal immunology, Asthma complications, Asthma immunology, Case-Control Studies, Chi-Square Distribution, Eicosanoids immunology, Endoscopy, Female, Humans, Male, Middle Aged, Nasal Polyps complications, Nasal Polyps immunology, Rhinitis complications, Rhinitis immunology, Severity of Illness Index, Sinusitis complications, Sinusitis immunology, Statistics, Nonparametric, Surveys and Questionnaires, Tomography, X-Ray Computed, Anti-Inflammatory Agents, Non-Steroidal adverse effects, Asthma chemically induced, Drug Hypersensitivity immunology, Eicosanoids blood, Nasal Polyps chemically induced, Rhinitis chemically induced, Sinusitis chemically induced
- Abstract
Background: Hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs) is often associated with chronic rhinosinusitis (CRS), nasal polyps (CRSwNP) and asthma, together known as Samter's triad. The disease is characterised by eicosanoid imbalance. In our study, we determined clinical and laboratory parameters in respect of three groups of patients: 1) CRSwNP, 2) CRSwNP and asthma (CRSwNP-A), and 3) CRSwNP with asthma and NSAID-triggered hypersensitivity (CRSwNP-AA). Our main goal was to improve the characterisation of the stages of development in Samter's triad, pointing to the homogeneous or heterogeneous course of disease., Methodology: Forty-three patients (10 CRSwNP, 14 CRSwNP-A, 19 CRSwNP-AA) and 10 control subjects were included in the study. Nasal assessment using the CRS visual analogue score, endoscopy- and computer tomography scores, allergy tests, analysis of sinus surgeries, asthma severity and in vitro functional eicosanoid tests (FET) with peripheral blood leucocytes were performed., Results: The scores reflecting CRS symptoms such as nasal congestion, nasal discharge and smell impairment differed between the patients groups reflecting the severity of disease (CRSwNP-AA > CRSwNP-A > CRSwNP). Eicosanoid imbalance correlated with nasal congestion, nasal discharge and loss of smell., Conclusion: The data presented support the hypothesis of the continuous development of NSAID-triggered hypersensitivity, culminating in Samter's triad.
- Published
- 2013
- Full Text
- View/download PDF
45. Comparative effects of sandalwood seed oil on fatty acid profiles and inflammatory factors in rats.
- Author
-
Li G, Singh A, Liu Y, Sunderland B, and Li D
- Subjects
- Adipose Tissue drug effects, Adipose Tissue metabolism, Animals, Body Weight drug effects, Cytokines analysis, Cytokines blood, Eicosanoids analysis, Eicosanoids blood, Fatty Acids analysis, Fatty Acids, Omega-3 analysis, Fatty Acids, Omega-3 metabolism, Liver drug effects, Liver immunology, Liver metabolism, Male, Oleic Acids chemistry, Oleic Acids pharmacology, Plant Oils chemistry, Rats, Rats, Sprague-Dawley, Seeds chemistry, Sesquiterpenes chemistry, Cytokines immunology, Eicosanoids immunology, Fatty Acids metabolism, Plant Oils pharmacology, Santalum chemistry, Sesquiterpenes pharmacology
- Abstract
The aim of the present study was to investigate the effect of sandalwood seed oil on fatty acid (FA) profiles and inflammatory factors in rats. Fifty male Sprague-Dawley rats were randomly divided into five different dietary groups: 10 % soybean oil (SO), 10 % olive oil (OO), 10 % safflower oil (SFO), 10 % linseed oil (LSO) and 8 % sandalwood seed oil blended with 2 % SO (SWSO) for 8 weeks. The SWSO group had a higher total n-3 polyunsaturated fatty acids (PUFA) levels but lower n-6:n-3 PUFA ratios in both adipose tissue and liver than those in the SO, OO and SFO groups (p < 0.05). Although the SWSO group had a much lower 18:3n-3 level (4.51 %) in their dietary lipids than the LSO group (58.88 %), the levels of docosahexaenoic acid (DHA: 22:6n-3) in liver lipids and phospholipids of the SWSO group (7.52 and 11.77 %) were comparable to those of the LSO group (7.07 and 13.16 %). Ximenynic acid, a predominant acetylenic FA in sandalwood seed oil, was found to be highly incorporated into adipose tissue (13.73 %), but relatively lower in liver (0.51 %) in the SWSO group. The levels of prostaglandin F(2α), prostaglandin E₂, thromboxane B₂, leukotriene B₄, tumor necrosis factor-α and interleukin-1β in both liver and plasma were positively correlated with the n-6:n-3 ratios, suggesting that increased n-6 PUFA appear to increase the formation of pro-inflammatory cytokines, whereas n-3 PUFA exhibit anti-inflammatory activity. The present results suggest that sandalwood seed oil could increase tissue levels of n-3 PUFA, DHA and reduce the n-6:n-3 ratio, and may increase the anti-inflammatory activity in rats.
- Published
- 2013
- Full Text
- View/download PDF
46. Inflammation, allergy and asthma, complex immune origin diseases: mechanisms and therapeutic agents.
- Author
-
Naik SR and Wala SM
- Subjects
- Animals, Anti-Allergic Agents pharmacology, Anti-Inflammatory Agents pharmacology, Eicosanoids immunology, Heat-Shock Proteins antagonists & inhibitors, Humans, Immunity, Cellular drug effects, Molecular Targeted Therapy, Patents as Topic, Prostaglandin-Endoperoxide Synthases metabolism, Signal Transduction drug effects, Anti-Allergic Agents therapeutic use, Anti-Inflammatory Agents therapeutic use, Asthma drug therapy, Hypersensitivity drug therapy, Inflammation drug therapy
- Abstract
Inflammation, allergy and asthma are the manifestation of multitude reactions of biological, cellular and immunological events. The various associated biological, cellular, and molecular events with inflammation, allergy and asthma participate to induce increased vascular permeability, vasodilatation, cellular migration, increased mucus secretion, broncho-constriction, structural changes of airway architecture, decline in pulmonary functions, release of intracellular mediators, increased formation of reactive oxygen species, cartilage degradation and loss of function. The participation of variety of effector cells viz. leukocytes, neutrophils, eosinophils, basophils, monocytes, macrophages, mast cells, dendritic cells, T-cells, B-cells, NK-cells, lead to cascade of events trigger of intracellular mediators (cytokines, chemokines etc.) activating diverse biological effects and immune responses. Eicosanoids are major precursors in cyclooxygenase and lipooxygenase pathways and play an important role in inflammation, allergy and asthma. Such biological and cellular events are further enhanced by stress related effects. The wide varieties of synthetic and natural compounds have been showed to act on different molecular targets (receptor, enzymes, mediators, and cells) involved in inflammation, allergy and asthma and to alter produce specific/definite therapeutic activity. The present review describes pathogenesis and etiological aspects of inflammation, allergy and asthma with few relevant patents which would be immensely useful for researchers in the field of immunology and molecular pharmacology to explore new avenues/strategies for development of new generation of therapeutically active agents for treatment of inflammation and allergic disorders.
- Published
- 2013
47. Cytokines in the balance of protection and pathology during mycobacterial infections.
- Author
-
Torrado E and Cooper AM
- Subjects
- Disease Susceptibility, Eicosanoids immunology, Host-Pathogen Interactions immunology, Humans, Immunity, Innate, Interleukins immunology, Lectins, C-Type immunology, Macrophages immunology, Macrophages microbiology, Models, Immunological, Mycobacterium Infections microbiology, Mycobacterium Infections pathology, Mycobacterium tuberculosis immunology, Nod Signaling Adaptor Proteins immunology, Phagocytosis, T-Lymphocyte Subsets immunology, Toll-Like Receptors immunology, Tumor Necrosis Factor-alpha immunology, Cytokines physiology, Mycobacterium Infections immunology
- Abstract
The outcome of natural infections with pathogenic mycobacteria can range from early asymptomatic clearance through latent infection to clinical disease. Different host and pathogen-specific factors have been implicated in determining the outcome of these infections; however, it is clear that the interaction of mycobacteria with the innate and acquired components of the immune system plays a central role. Specifically, the recognition of mycobacterial components by innate immune cells through different pathogen recognition receptors (PPRs) induces a cytokine response that can promote early control of the infection. In fact, in the majority of individuals that come into contact with mycobacteria, this response is enough to control the infection. Among PRRs, Toll-like receptors (TLRs), Nucleotide Oligomerization Domain (NOD)-like receptors, and C-type lectins have all been implicated in recognition of mycobacteria and in the initiation of the cytokine response. Defining the mechanisms by which distinct mycobacterial components and their receptors stimulate the immune response is an area of intense research.
- Published
- 2013
- Full Text
- View/download PDF
48. Bioactive lipid mediators in skin inflammation and immunity.
- Author
-
Kendall AC and Nicolaou A
- Subjects
- Acne Vulgaris immunology, Acne Vulgaris metabolism, Eicosanoids metabolism, Endocannabinoids immunology, Humans, Lipids chemistry, Lipids immunology, Psoriasis immunology, Psoriasis metabolism, Skin chemistry, Skin metabolism, Sphingolipids immunology, Sphingolipids metabolism, Dermatitis immunology, Dermatitis metabolism, Eicosanoids immunology, Lipid Metabolism immunology, Skin immunology, Wound Healing immunology
- Abstract
The skin is the primary barrier from the outside environment, protecting the host from injury, infectious pathogens, water loss and solar ultraviolet radiation. In this role, it is supported by a highly organized system comprising elements of innate and adaptive immunity, responsive to inflammatory stimuli. The cutaneous immune system is regulated by mediators such as cytokines and bioactive lipids that can initiate rapid immune responses with controlled inflammation, followed by efficient resolution. However, when immune responses are inadequate or mounted against non-infectious agents, these mediators contribute to skin pathologies involving unresolved or chronic inflammation. Skin is characterized by active lipid metabolism and fatty acids play crucial roles both in terms of structural integrity and functionality, in particular when transformed to bioactive mediators. Eicosanoids, endocannabinoids and sphingolipids are such key bioactive lipids, intimately involved in skin biology, inflammation and immunity. We discuss their origins, role and influence over various cells of the epidermis, dermis and cutaneous immune system and examine their function in examples of inflammatory skin conditions. We focus on psoriasis, atopic and contact dermatitis, acne vulgaris, wound healing and photodermatology that demonstrate dysregulation of bioactive lipid metabolism and examine ways of using this insight to inform novel therapeutics., (Copyright © 2012 Elsevier Ltd. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
49. Anti-inflammatory mechanism of action of azithromycin in LPS-stimulated J774A.1 cells.
- Author
-
Banjanac M, Munić Kos V, Nujić K, Vrančić M, Belamarić D, Crnković S, Hlevnjak M, and Eraković Haber V
- Subjects
- Animals, Anti-Bacterial Agents immunology, Anti-Inflammatory Agents immunology, Anti-Inflammatory Agents, Non-Steroidal immunology, Anti-Inflammatory Agents, Non-Steroidal pharmacology, Arachidonic Acid immunology, Azithromycin immunology, Cell Line, Dinoprostone immunology, Eicosanoids immunology, Group IV Phospholipases A2 antagonists & inhibitors, Indomethacin immunology, Indomethacin pharmacology, Interleukin-12 Subunit p40 immunology, Interleukin-6 immunology, Macrophages metabolism, Mice, Prostaglandin-Endoperoxide Synthases genetics, RNA, Messenger genetics, Tumor Necrosis Factor-alpha immunology, Anti-Bacterial Agents pharmacology, Anti-Inflammatory Agents pharmacology, Azithromycin pharmacology, Lipopolysaccharides immunology, Macrophages drug effects, Macrophages immunology
- Abstract
Azithromycin is a macrolide antibiotic with well-described anti-inflammatory properties which can be attributed, at least partially, to its action on macrophages. We have previously shown, with 18 different macrolide molecules, that IL-6 and PGE₂ inhibition correlates with macrolide accumulation, as well as with their binding to phospholipids in J774A.1 cells. The present study was performed in order to substantiate the hypothesis that biological membranes are a target for macrolide anti-inflammatory activity. By analyzing the effect of azithromycin on overall eicosanoid production, we found that in LPS-stimulated J774A.1 cells, azithromycin, like indomethacin, inhibited the synthesis of all eicosanoids produced downstream of COX. Upstream of COX, azithromycin inhibited arachidonic acid release in the same way as a cPLA₂ inhibitor, while indomethacin had no effect. Further comparison revealed that in LPS-stimulated J774A.1 cells, the cPLA₂ inhibitor showed the same profile of inhibition as azithromycin in inhibiting PGE₂, IL-6, IL-12p40 and arachidonic acid release. Therefore, we propose that the anti-inflammatory activity of azithromycin in this model may be due to interactions with cPLA₂, causing inadequate translocation of the enzyme or disturbing physical interactions with its substrates., (Copyright © 2012 Elsevier Ltd. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
50. New families of bioactive oxidized phospholipids generated by immune cells: identification and signaling actions.
- Author
-
O'Donnell VB and Murphy RC
- Subjects
- Animals, Blood Platelets immunology, Blood Platelets metabolism, Cell Communication, Eicosanoids immunology, Eicosanoids metabolism, Humans, Immunity, Innate, Macrophages immunology, Mass Spectrometry, Mice, Monocytes immunology, Oxidation-Reduction, Phosphatidylcholines immunology, Phosphatidylcholines metabolism, Phosphatidylethanolamines immunology, Phosphatidylethanolamines metabolism, Signal Transduction, Eicosanoids chemistry, Macrophages metabolism, Monocytes metabolism, Phosphatidylcholines chemistry, Phosphatidylethanolamines chemistry
- Abstract
Phospholipids are of critical importance in mammalian cell biology, both through providing a permeability barrier and acting as substrates for synthesis of lipid mediators. Recently, several new families of bioactive lipids were identified that form through the enzymatic oxidation of membrane phospholipids in circulating innate immune cells and platelets. These comprise eicosanoids attached to phosphatidylethanolamine and phosphatidylcholine and form within 2-5 minutes of cell activation by pathophysiologic agonists, via the coordinated action of receptors and enzymes. In this review, we summarize what is currently known regarding their structures, mechanisms of formation, cell biology, and signaling actions. We show that phospholipid oxidation by acutely activated immune cells is a controlled event, and we propose a central role in regulating membrane biology and innate immune function during health and disease. We also review the mass spectrometry methods used for identification of the lipids and describe how these approaches can be used for discovery of new lipid mediators in complex biologic samples.
- Published
- 2012
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.